| | |
PER ADS
|
| |
TOTAL
|
| ||||||
公開發行價 | | | | $ | 10.00 | | | | | $ | 30,000,000 | | |
承保折扣和佣金(1) | | | | $ | 0.70 | | | | | $ | 2,100,000 | | |
未扣除費用的收益 | | | | $ | 9.30 | | | | | $ | 27,900,000 | | |
| | |
Page
|
| |||
PROSPECTUS SUMMARY
|
| | | | 1 | | |
THE OFFERING
|
| | | | 11 | | |
SUMMARY FINANCIAL DATA
|
| | | | 13 | | |
RISK FACTORS
|
| | | | 15 | | |
有關前瞻性陳述的警示説明
|
| | | | 95 | | |
市場、行業等數據
|
| | | | 97 | | |
USE OF PROCEEDS
|
| | | | 98 | | |
DIVIDEND POLICY
|
| | | | 99 | | |
CAPITALIZATION
|
| | | | 100 | | |
DILUTION
|
| | | | 101 | | |
選定的財務數據
|
| | | | 103 | | |
管理層對財務狀況和經營成果的討論和分析
|
| | | | 105 | | |
BUSINESS
|
| | | | 119 | | |
MANAGEMENT
|
| | | | 182 | | |
關聯方交易
|
| | | | 196 | | |
主要股東
|
| | | | 197 | | |
股本説明
|
| | | | 199 | | |
美國存托股份説明
|
| | | | 212 | | |
未來有資格出售的普通股和美國存託憑證
|
| | | | 220 | | |
TAXATION
|
| | | | 223 | | |
UNDERWRITING
|
| | | | 231 | | |
EXPENSES OF THE OFFERING
|
| | | | 237 | | |
LEGAL MATTERS
|
| | | | 238 | | |
EXPERTS
|
| | | | 239 | | |
訴訟程序的送達和民事責任的執行
|
| | | | 240 | | |
您可以在哪裏找到更多信息
|
| | | | 241 | | |
財務報表索引
|
| | | | F-1 | | |
| | |
For the Years Ended
December 31, |
| |
For the Nine Months Ended
September 30, |
| ||||||||||||||||||
| | |
(單位為千美元,每股數據除外)
|
| |||||||||||||||||||||
| | |
2018
|
| |
2019
|
| |
2019
|
| |
2020
|
| ||||||||||||
| | | | | | | | | | | | | | |
(unaudited)
|
| |||||||||
研發費用
|
| | | $ | 3,729 | | | | | $ | 8,216 | | | | | | 5,270 | | | | | | 8,048 | | |
一般和行政費用
|
| | | | 1,898 | | | | | | 2,647 | | | | | | 1,870 | | | | | | 3,875 | | |
Operating loss
|
| | | | (5,627) | | | | | | (10,863) | | | | | | (7,140) | | | | | | (11,923) | | |
Finance income
|
| | | | 76 | | | | | | 65 | | | | | | 84 | | | | | | 123 | | |
Finance expense
|
| | | | (719) | | | | | | (1,222) | | | | | | (1,186) | | | | | | (9) | | |
Net loss before tax
|
| | | | (6,270) | | | | | | (12,020) | | | | | | (8,242) | | | | | | (11,809) | | |
Income taxes
|
| | | | 735 | | | | | | 825 | | | | | | 566 | | | | | | 1,055 | | |
Net loss for the period
|
| | | $ | (5,535) | | | | | $ | (11,195) | | | | | $ | (7,676) | | | | | $ | (10,754) | | |
Evaxion股東應佔淨虧損
Biotech A/S |
| | | $ | (5,535) | | | | | $ | (11,195) | | | | | $ | (7,676) | | | | | $ | (10,754) | | |
Loss per share – basic and diluted(1)
|
| | | $ | (0.43) | | | | | $ | (0.81) | | | | | $ | (0.57) | | | | | $ | (0.71) | | |
| | |
As of September 30, 2020
|
| |||||||||||||||
| | |
Actual
|
| |
Pro
Forma(1) |
| |
Pro Forma
As Adjusted(2) |
| |||||||||
(in thousands) | | | | | | | | | | | | | | | |||||
合併財務狀況表: | | | | | | | | | | | | | | | |||||
Cash and cash equivalents
|
| | | $ | 7,876 | | | | | $ | 10,268 | | | | | $ | 36,605 | | |
Total assets
|
| | | | 11,275 | | | | | | 13,667 | | | | | | 39,373 | | |
Total liabilities
|
| | | | 3,372 | | | | | | 3,372 | | | | | | 3,372 | | |
Share capital
|
| | | | 2,603 | | | | | | 2,645 | | | | | | 3,125 | | |
Other reserves
|
| | | | 29,067 | | | | | | 31,417 | | | | | | 56,643 | | |
Accumulated deficit
|
| | | | (23,767) | | | | | | (23,767) | | | | | | (23,767) | | |
Total equity
|
| | | $ | 7,903 | | | | | $ | 10,295 | | | | | $ | 36,001 | | |
(除每股和每股數據外,以千為單位)
|
| |
Actual
|
| |
Pro Forma
|
| |
Pro Forma
As Adjusted |
| |||||||||
現金和現金等價物
|
| | | $ | 7,876 | | | | | $ | 10,268 | | | | | $ | 36,605 | | |
Total liabilities
|
| | | | 3,372 | | | | | | 3,372 | | | | | | 3,372 | | |
Equity | | | | | | | | | | | | | | | | | | | |
Share capital
|
| | | | 2,603 | | | | | | 2,645 | | | | | | 3,125 | | |
其他儲量
|
| | | | 29,067 | | | | | | 31,417 | | | | | | 56,643 | | |
Accumulated deficit
|
| | | | (23,767) | | | | | | (23,767) | | | | | | (23,767) | | |
Total equity
|
| | | | 7,903 | | | | | | 10,295 | | | | | | 36,001 | | |
總市值
|
| | | $ | 11,275 | | | | | $ | 13,667 | | | | | $ | 39,373 | | |
|
每個美國存托股份的首次公開募股價格
|
| | | | | | | | | $ | 10.00 | | |
|
截至2020年9月30日的歷史美國存托股份有形賬面淨值
|
| | | | 0.45 | | | | | | | | |
|
美國存托股份在本次發行完成前發行和出售269,136股普通股,預計有形賬面淨值增加
|
| | | | 0.14 | | | | | | | | |
|
預計截至2020年9月30日的美國存托股份有形賬面淨值
|
| | | | 0.59 | | | | | | | | |
|
可歸因於新投資者的美國存托股份預計有形賬面淨值增加
參與此次活動 |
| | | | 1.28 | | | | | | | | |
|
預計上市後每個美國存托股份的調整後有形賬面淨值
|
| | | | | | | | | | 1.87 | | |
|
按美國存托股份向參與此次發行的新投資者攤薄
|
| | | | | | | | | $ | 8.13 | | |
| | |
Ordinary Shares
Purchased |
| |
Total Consideration
|
| |
Average
Price Per Share |
| |
Average
Price Per ADS |
| ||||||||||||||||||||||||
| | |
Number
|
| |
Percent
|
| |
Amount
|
| |
Percent
|
| ||||||||||||||||||||||||
現有股東
|
| | | | 16,198,668 | | | | | | 84.4% | | | | | $ | 34,062,000 | | | | | | 53.2% | | | | | $ | 2.10 | | | | | $ | 2.10 | | |
New investors
|
| | | | 3,000,000 | | | | | | 15.6% | | | | | | 30,000,000 | | | | | | 46.8% | | | | | | 10.00 | | | | | | 10.00 | | |
Total
|
| | | | 19,198,668 | | | | | | 100% | | | | | $ | 64,062,000 | | | | | | 100% | | | | | $ | 3.34 | | | | | $ | 3.34 | | |
| | |
For the Years Ended
December 31, |
| |
For the Nine Months Ended
September 30, |
| ||||||||||||||||||
| | |
(單位為千美元,每股數據除外)
|
| |||||||||||||||||||||
| | |
2018
|
| |
2019
|
| |
2019
|
| |
2020
|
| ||||||||||||
| | | | | | | | | | | | | | |
(unaudited)
|
| |||||||||
研發費用
|
| | | $ | 3,729 | | | | | $ | 8,216 | | | | | | 5,270 | | | | | | 8,048 | | |
一般和行政費用
|
| | | | 1,898 | | | | | | 2,647 | | | | | | 1,870 | | | | | | 3,875 | | |
Operating loss
|
| | | | (5,627) | | | | | | (10,863) | | | | | | (7,140) | | | | | | (11,923) | | |
Finance income
|
| | | | 76 | | | | | | 65 | | | | | | 84 | | | | | | 123 | | |
Finance expense
|
| | | | (719) | | | | | | (1,222) | | | | | | (1,186) | | | | | | (9) | | |
Net loss before tax
|
| | | | (6,270) | | | | | | (12,020) | | | | | | (8,242) | | | | | | (11,809) | | |
Income taxes
|
| | | | 735 | | | | | | 825 | | | | | | 566 | | | | | | 1,055 | | |
Net loss for the period
|
| | | $ | (5,535) | | | | | $ | (11,195) | | | | | $ | (7,676) | | | | | $ | (10,754) | | |
Evaxion Biotech股東應佔淨虧損
A/S |
| | | $ | (5,535) | | | | | $ | (11,195) | | | | | $ | (7,676) | | | | | $ | (10,754) | | |
Loss per share – basic and diluted
|
| | | $ | (0.43) | | | | | $ | (0.81) | | | | | $ | (0.57) | | | | | $ | (0.71) | | |
| | |
As of
|
| |||||||||||||||
| | |
December 31,
|
| |
September 30,
|
| ||||||||||||
| | |
2018
|
| |
2019
|
| |
2020
|
| |||||||||
(in thousands)
|
| | | | | | | | | | | | | |
(unaudited)
|
| |||
合併財務狀況表: | | | | | | | | | | | | | | | | | | | |
現金和現金等價物
|
| | | $ | 7,433 | | | | | $ | 9,559 | | | | | $ | 7,876 | | |
Total assets
|
| | | | 8,513 | | | | | | 11,084 | | | | | | 11,275 | | |
Total liabilities
|
| | | | 9,444 | | | | | | 1,722 | | | | | | 3,372 | | |
Share capital
|
| | | | 2,113 | | | | | | 2,481 | | | | | | 2,603 | | |
Other reserves
|
| | | | 3,935 | | | | | | 22,693 | | | | | | 29,067 | | |
Accumulated deficit
|
| | | | (6,979) | | | | | | (15,812) | | | | | | (23,767) | | |
Total equity
|
| | | | (931) | | | | | | 9,362 | | | | | | 7,903 | | |
| | |
截至9月30日的9個月
|
| | | | | | | |||||||||
| | |
2019
|
| |
2020
|
| |
Change
|
| |||||||||
| | |
(USD in thousands)
|
| | ||||||||||||||
Operating expenses: | | | | | | | | | | | | | | | | | | | |
研發
|
| | | $ | 5,270 | | | | | $ | 8,048 | | | | | $ | 2,778 | | |
一般和行政
|
| | | | 1,870 | | | | | | 3,875 | | | | | | 2,005 | | |
總運營費用
|
| | | | 7,140 | | | | | | 11,923 | | | | | | 4,783 | | |
Operating loss
|
| | | | (7,140) | | | | | | (11,923) | | | | | | (4,783) | | |
Finance income
|
| | | | 84 | | | | | | 123 | | | | | | 39 | | |
Finance expenses
|
| | | | (1,186) | | | | | | (9) | | | | | | 1,177 | | |
Net loss before tax
|
| | | | (8,242) | | | | | | (11,809) | | | | | | (3,567) | | |
Income taxes
|
| | | | 566 | | | | | | 1,055 | | | | | | 489 | | |
Net loss for the period
|
| | | $ | (7,676) | | | | | $ | (10,754) | | | | | $ | (3,078) | | |
| | |
September 30, 2020
|
| |||||||||||||||||||||||||||||||||
(USD in thousands)
|
| |
Carrying
amount |
| |
Contractual
cash flows |
| |
|
| |
1 – 5 years
|
| |
>5 years
|
| |
Total
|
| ||||||||||||||||||
Lease liabilities
|
| | | $ | 38 | | | | | $ | 38 | | | | | $ | 38 | | | | | $ | — | | | | | $ | — | | | | | $ | 38 | | |
Trade payables
|
| | | | 1,502 | | | | | | 1,502 | | | | | | 1,502 | | | | | | — | | | | | | — | | | | | | 1,502 | | |
Other payables
|
| | | | 1,832 | | | | | | 1,832 | | | | | | 1,832 | | | | | | — | | | | | | — | | | | | | 1,832 | | |
Total
|
| | | $ | 3,372 | | | | | $ | 3,372 | | | | | $ | 3,372 | | | | | $ | — | | | | | $ | — | | | | | $ | 3,372 | | |
| | |
截至9月30日的9個月
|
| |||||||||
| | |
2019
|
| |
2020
|
| ||||||
| | |
(USD in thousands)
|
| |||||||||
Cash Flow Data: | | | | | | | | | | | | | |
經營活動中使用的淨現金
|
| | | $ | (4,812) | | | | | $ | (8,045) | | |
投資活動中使用的淨現金
|
| | | | (14) | | | | | | (112) | | |
融資活動提供的現金淨額
|
| | | | 9,264 | | | | | | 6,444 | | |
現金和現金等價物淨增長
|
| | | $ | 4,438 | | | | | $ | (1,713) | | |
| | |
Years Ended December 31,
|
| | | | | | | |||||||||
| | |
2018
|
| |
2019
|
| |
Change
|
| |||||||||
| | |
(USD in thousands,
except per share amounts) |
| |||||||||||||||
Operating expenses: | | | | | | | | | | | | | | | | | | | |
研發
|
| | | $ | 3,729 | | | | | $ | 8,216 | | | | | $ | 4,487 | | |
一般和行政
|
| | | | 1,898 | | | | | | 2,647 | | | | | | 749 | | |
總運營費用
|
| | | | 5,627 | | | | | | 10,863 | | | | | | 5,236 | | |
Operating loss
|
| | | | (5,627) | | | | | | (10,863) | | | | | | (5,236) | | |
Finance income
|
| | | | 76 | | | | | | 65 | | | | | | (11) | | |
Finance expenses
|
| | | | (719) | | | | | | (1,222) | | | | | | (503) | | |
Net loss before tax
|
| | | | (6,270) | | | | | | (12,020) | | | | | | (5,750) | | |
Income taxes
|
| | | | 735 | | | | | | 825 | | | | | | 90 | | |
Net loss for the year
|
| | | $ | (5,535) | | | | | $ | (11,195) | | | | | $ | (5,660) | | |
| | |
Years Ended
December 31, |
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
| | |
(USD in thousands)
|
| |||||||||
Cash Flow Data: | | | | | | | | | | | | | |
經營活動中使用的淨現金
|
| | | $ | (1,978) | | | | | $ | (7,026) | | |
投資活動中使用的淨現金
|
| | | | (7) | | | | | | (61) | | |
融資活動提供的現金淨額
|
| | | | 9,027 | | | | | | 9,508 | | |
現金和現金等價物淨增長
|
| | | $ | 7,042 | | | | | $ | 2,421 | | |
| | |
Payments Due by Period
|
| |||||||||||||||||||||||||||
(USD in thousands)
|
| |
Within 1 Year
|
| |
1 – 2 Years
|
| |
2 – 5 Years
|
| |
Over 5 Years
|
| |
Total
|
| |||||||||||||||
Leases
|
| | | $ | 55 | | | | | $ | – | | | | | $ | – | | | | | $ | – | | | | | $ | 55 | | |
Purchase obligations(1)
|
| | | | 587 | | | | | | 103 | | | | | | 20 | | | | | | – | | | | | | 710 | | |
Total(2)(3)(4)
|
| | | $ | 642 | | | | | $ | 103 | | | | | $ | 20 | | | | | $ | – | | | | | $ | 765 | | |
Outstanding program
|
| |
Per warrant
weighted average grant date fair value (DKK) |
| |
Per warrant
weighted average grant date fair value (USD) |
| ||||||
Grant (December 2016)
|
| | | | 20.91 | | | | | | 3.13 | | |
Grant (April 2017)
|
| | | | 24.05 | | | | | | 3.60 | | |
Grant (September 2017)
|
| | | | 28.71 | | | | | | 4.30 | | |
Grant (December 2017)
|
| | | | 28.71 | | | | | | 4.30 | | |
Granted (during 2018)
|
| | | | 37.05 | | | | | | 5.55 | | |
Granted (January 2019)
|
| | | | 37.05 | | | | | | 5.55 | | |
Granted (February 2019)
|
| | | | 42.57 | | | | | | 6.38 | | |
Granted (September 2019)
|
| | | | 56.35 | | | | | | 8.44 | | |
Granted (October 2019)
|
| | | | 56.97 | | | | | | 8.53 | | |
Bacterial species
|
| |
In vivo
PoC |
| |
體內模型(小鼠挑戰模型)
|
| |
IP
filed |
|
金黃色葡萄球菌
|
| |
✓
|
| | 致死性腹膜炎和皮膚膿腫模型 | | |
✓
|
|
銅綠假單胞菌
|
| |
✓
|
| | 致死性腹膜炎和致死性急性肺炎模型 | | |
✓
|
|
非分型流感嗜血桿菌
|
| |
✓
|
| | 肺定植模型 | | |
✓
|
|
卡他莫拉氏菌
|
| |
✓
|
| | 致死性腹膜炎和肺定植模型 | | |
✓
|
|
淋病奈瑟菌
|
| |
✓
|
| | 陰道定植模型 | | |
✓
|
|
鮑曼不動桿菌
|
| |
✓
|
| | 致死性急性肺炎模型 | | |
✓
|
|
肺炎克雷伯菌
|
| |
✓
|
| | 致死性腹膜炎和致死性急性肺炎模型 | | |
✓
|
|
|
#
|
| |
Protein ID
|
| |
No. of
Experiments |
| |
No. of
Test Mice |
| |
No. of
Control Mice |
| |
%
Survival of Test Mice |
| |
%
Survival of Control Mice |
| |
Difference in
% Survival (Test vs. Control) |
| |||||||||||||||||||||
|
1
|
| | | | 伊甸園-1 | | | | | | 4 | | | | | | 59 | | | | | | 60 | | | | | | 76% | | | | | | 28% | | | | | | 48% | | |
|
2
|
| | | | 伊甸園-2 | | | | | | 2 | | | | | | 24 | | | | | | 24 | | | | | | 58% | | | | | | 13% | | | | | | 46% | | |
|
3
|
| | | | 伊甸園-3 | | | | | | 3 | | | | | | 43 | | | | | | 44 | | | | | | 77% | | | | | | 32% | | | | | | 45% | | |
|
4
|
| | | | 伊甸園-4 | | | | | | 2 | | | | | | 28 | | | | | | 28 | | | | | | 68% | | | | | | 25% | | | | | | 43% | | |
|
5
|
| | | | 伊甸園-5 | | | | | | 2 | | | | | | 28 | | | | | | 28 | | | | | | 68% | | | | | | 25% | | | | | | 43% | | |
|
6
|
| | | | 伊甸園-6 | | | | | | 2 | | | | | | 27 | | | | | | 28 | | | | | | 85% | | | | | | 43% | | | | | | 42% | | |
|
7
|
| | | | 伊甸園-7 | | | | | | 3 | | | | | | 36 | | | | | | 36 | | | | | | 61% | | | | | | 19% | | | | | | 42% | | |
|
8
|
| | | | 伊甸園-8 | | | | | | 5 | | | | | | 61 | | | | | | 64 | | | | | | 51% | | | | | | 9% | | | | | | 41% | | |
|
9
|
| | | | 伊甸園-9 | | | | | | 3 | | | | | | 43 | | | | | | 44 | | | | | | 63% | | | | | | 30% | | | | | | 33% | | |
|
10
|
| | | | 伊甸園-10 | | | | | | 3 | | | | | | 36 | | | | | | 36 | | | | | | 69% | | | | | | 36% | | | | | | 33% | | |
|
11
|
| | | | 伊甸園-11 | | | | | | 3 | | | | | | 32 | | | | | | 35 | | | | | | 53% | | | | | | 20% | | | | | | 33% | | |
|
12
|
| | | | 伊甸園-12 | | | | | | 3 | | | | | | 42 | | | | | | 42 | | | | | | 62% | | | | | | 31% | | | | | | 31% | | |
|
13
|
| | | | 伊甸園-13 | | | | | | 3 | | | | | | 36 | | | | | | 36 | | | | | | 47% | | | | | | 28% | | | | | | 19% | | |
|
|
| |
|
|
Function
|
| |
Number
|
| |||
臨牀研究與開發
|
| | | | 6 | | |
科學研究與開發
|
| | | | 21 | | |
Supporting Functions
|
| | | | 4 | | |
商業和商業發展
|
| | | | 4 | | |
TOTAL
|
| | |
|
35
|
| |
Region
|
| |
Number
|
| |||
Capital Region, Denmark
|
| | | | 34 | | |
New York, United States
|
| | | | 1 | | |
TOTAL
|
| | |
|
35
|
| |
Name
|
| |
Position
|
| |
Age
|
| |
Independent
|
| |
Year of first
appointment |
| |
Expiration
of current term |
|
Marianne Søgaard(1)
|
| | Member | | |
52
|
| |
No
|
| |
2020
|
| |
2021
|
|
Steven Projan(2)(3)
|
| | Member | | |
68
|
| |
Independent
|
| |
2018
|
| |
2021
|
|
Roberto Prego(1)(2)
|
| | Member | | |
50
|
| |
Independent
|
| |
2018
|
| |
2021
|
|
Jo Ann Suzich(3)
|
| | Member | | |
65
|
| |
Independent
|
| |
2019
|
| |
2021
|
|
Helen M. Boudreau(2)
|
| | Member | | |
54
|
| |
Independent
|
| |
2020
|
| |
2021
|
|
Name
|
| |
Age
|
| |
Position(s)
|
| |||
執行管理層: | | | | | | | | | | |
Lars Staal Wegner, M.D.
|
| | | | 46 | | | | 首席執行官 | |
Glenn S. Vraniak
|
| | | | 58 | | | | 首席財務官 | |
Erik Deichmann Heegaard,博士,DMSc
|
| | | | 53 | | | | 首席醫療官 | |
Niels Iversen Møller, M.D.
|
| | | | 42 | | | | 首席商務官 | |
Andreas Holm Mattsson
|
| | | | 45 | | | | 首席創新官 | |
| | |
Years Ended
December 31, |
| |||||||||
(in thousands of USD)
|
| |
2018
|
| |
2019
|
| ||||||
Lars Staal Wegner(CEO) | | | | | | | | | | | | | |
Salary
|
| | | | 220 | | | | | | 238 | | |
Bonus
|
| | | | 6 | | | | | | 0 | | |
其他員工福利
|
| | | | 0 | | | | | | 0 | | |
Total
|
| | | | 226 | | | | | | 238 | | |
Glenn S. Vraniak (CFO) | | | | | | | | | | | | | |
Salary
|
| | | | 0 | | | | | | 88 | | |
Bonus
|
| | | | 0 | | | | | | 0 | | |
Total
|
| | | | 0 | | | | | | 88 | | |
Niels Iverson Møller (CBO) | | | | | | | | | | | | | |
Salary
|
| | | | 173 | | | | | | 175 | | |
Bonus
|
| | | | 5 | | | | | | 0 | | |
其他員工福利
|
| | | | 0 | | | | | | 0 | | |
Total
|
| | | | 178 | | | | | | 175 | | |
安德烈亞斯·霍姆·馬特森(CIO) | | | | | | | | | | | | | |
Salary
|
| | | | 179 | | | | | | 175 | | |
Bonus
|
| | | | 5 | | | | | | 0 | | |
其他員工福利
|
| | | | 0 | | | | | | 0 | | |
Total
|
| | | | 184 | | | | | | 175 | | |
| | |
Years Ended
December 31, |
| |||||||||
(in thousands of USD)
|
| |
2018
|
| |
2019
|
| ||||||
不包括執行管理層和董事會的員工成本 | | | | | | | | | | | | | |
Salaries
|
| | | | 1,112 | | | | | | 1,919 | | |
Cash bonus
|
| | | | 0 | | | | | | 0 | | |
基於股份的薪酬
|
| | | | 387 | | | | | | 1,055 | | |
Pensions
|
| | | | 70 | | | | | | 96 | | |
其他社保繳費
|
| | | | 10 | | | | | | 12 | | |
Other staff costs
|
| | | | 133 | | | | | | 176 | | |
員工總成本,不包括執行管理層和董事會
|
| | | | 1,712 | | | | | | 3,258 | | |
高管薪酬 | | | | | | | | | | | | | |
Salaries
|
| | | | 621 | | | | | | 900 | | |
Cash bonus
|
| | | | 0 | | | | | | 0 | | |
基於股份的薪酬
|
| | | | 1,157 | | | | | | 956 | | |
Pensions
|
| | | | 0 | | | | | | 0 | | |
其他社保繳費
|
| | | | 0 | | | | | | 0 | | |
Other staff costs
|
| | | | 0 | | | | | | 0 | | |
高管薪酬總額
|
| | | | 1,778 | | | | | | 1,856 | | |
董事會薪酬 | | | | | | | | | | | | | |
Board and committee fees
|
| | | | 0 | | | | | | 0 | | |
Travel allowance
|
| | | | 0 | | | | | | 0 | | |
基於股份的薪酬
|
| | | | 525 | | | | | | 351 | | |
董事會薪酬總額
|
| | | | 525 | | | | | | 351 | | |
Total employee costs
|
| | | | 4,015 | | | | | | 5,465 | | |
在全面損失表中確認如下: | | | | | | | | | | | | | |
研發費用
|
| | | | 2,652 | | | | | | 3,607 | | |
一般和行政費用
|
| | | | 1,363 | | | | | | 1,858 | | |
Total employee costs
|
| | | | 4,015 | | | | | | 5,465 | | |
全職員工平均人數
|
| | | | 18 | | | | | | 25 | | |
Number of full-time employees – December 31, 2019
|
| | | | 20 | | | | | | 36 | | |
| | |
Years Ended
December 31, |
| |||||||||
(in thousands of DKK)
|
| |
2018
|
| |
2019
|
| ||||||
Kim Bjoernstrup(董事會主席)(1) | | | | | | | | | | | | | |
Board and committee fees
|
| | | | 0 | | | | | | 0 | | |
Travel allowance
|
| | | | 0 | | | | | | 0 | | |
基於股份的薪酬
|
| | | | 0 | | | | | | 0 | | |
Total
|
| | | | 0 | | | | | | 0 | | |
|
| | |
Years Ended
December 31, |
| |||||||||
(in thousands of DKK)
|
| |
2018
|
| |
2019
|
| ||||||
Helen M. Boudreau | | | | | | | | | | | | | |
Board and committee fees
|
| | | | 0 | | | | | | 0 | | |
Travel allowance
|
| | | | 0 | | | | | | 0 | | |
基於股份的薪酬
|
| | | | 0 | | | | | | 0 | | |
Total
|
| | | | 0 | | | | | | 0 | | |
Roberto Prego | | | | | | | | | | | | | |
Board and committee fees
|
| | | | 0 | | | | | | 0 | | |
Travel allowance
|
| | | | 0 | | | | | | 0 | | |
基於股份的薪酬
|
| | | | 0 | | | | | | 410 | | |
Total
|
| | | | 0 | | | | | | 410 | | |
Steven Projan | | | | | | | | | | | | | |
Board and committee fees
|
| | | | 0 | | | | | | 0 | | |
Travel allowance
|
| | | | 0 | | | | | | 0 | | |
基於股份的薪酬
|
| | | | 868 | | | | | | 654 | | |
Total
|
| | | | 868 | | | | | | 654 | | |
Jo Ann Suzich | | | | | | | | | | | | | |
Board and committee fees
|
| | | | 0 | | | | | | 0 | | |
Travel allowance
|
| | | | 0 | | | | | | 0 | | |
基於股份的薪酬
|
| | | | 0 | | | | | | 174 | | |
Total
|
| | | | 0 | | | | | | 174 | | |
|
Name
|
| |
Grant Date
|
| |
Number of Ordinary
Shares Underlying Warrants(2) |
| |
Warrant
Exercise Price DKK |
| |
Warrant
Expiration Date |
| ||||||
Marianne Søgaard (Chairperson)(1)
|
| | 2018/2019/2020 | | | | | 94,320 | | | | | | 1 | | | |
December 31, 2036
|
|
Helen M. Boudreau (director)
|
| | 2020 | | | | | 5,436 | | | | | | 1 | | | |
December 31, 2036
|
|
Jo Ann Suzich (director)
|
| | 2019/2020 | | | | | 10,260 | | | | | | 1 | | | |
December 31, 2036
|
|
Roberto Prego (director)
|
| | 2017/2018/2020 | | | | | 27,036 | | | | | | 1 | | | |
December 31, 2036
|
|
Steven Projan (director)
|
| | 2018/2019/2020 | | | | | 42,048 | | | | | | 1 | | | |
December 31, 2036
|
|
Kim Bjoernstrup (director)(1)
|
| | — | | | | | 0 | | | | | | — | | | | — | |
Lars Staal Wegner (CEO)
|
| | 2016/2017/2018/2020 | | | | | 852,264 | | | | | | 1 | | | |
December 31, 2036
|
|
Niels Iverson Møller (CBO)
|
| | — | | | | | 0 | | | | | | — | | | | — | |
Andreas Holm Mattson (CIO)
|
| | — | | | | | 0 | | | | | | — | | | | — | |
Glenn S. Vraniak (CFO)
|
| | 2019 | | | | | 150,660 | | | | | | 1 | | | |
December 31, 2036
|
|
Position
|
| |
Retainer
|
| |||
Board Member
|
| | | $ | 40,000 | | |
Board Chairperson
|
| | | $ | 80,000 | | |
Audit Committee Chair
|
| | | $ | 15,000 | | |
薪酬委員會主席
|
| | | $ | 4,000 | | |
提名和公司治理委員會主席
|
| | | $ | 4,000 | | |
Audit Committee Member
|
| | | $ | 4,000 | | |
薪酬委員會成員
|
| | | $ | 4,000 | | |
提名和公司治理委員會主席
|
| | | $ | 4,000 | | |
Name of Beneficial Owner
|
| |
實益擁有的股份
before The Offering |
| |
實益擁有的股份
after The Offering |
| |
Percent of Shares
Beneficially Owned Assuming Full Exercise of Underwriters’ Option to Purchase Additional Shares |
| |||||||||||||||||||||
| | |
Number
|
| |
Percent
|
| |
Number
|
| |
Percent
|
| | | | | | | ||||||||||||
5%或更大股東 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
NIMedical Holding ApS(1)
|
| | | | 4,292,604 | | | | | | 26.50 | | | | | | 4,292,604 | | | | | | 22.36 | | | | | | 21.85 | | |
Mattsson Holding af 2008 ApS(2)
|
| | | | 4,163,832 | | | | | | 25.70 | | | | | | 4,163,832 | | | | | | 21.69 | | | | | | 21.19 | | |
Punga Punga C.V.(3)
|
| | | | 826,560 | | | | | | 5.10 | | | | | | 826,560 | | | | | | 4.31 | | | | | | 4.21 | | |
執行管理 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Lars Staal Wegner(4)
|
| | | | 182,124 | | | | | | 1.12 | | | | | | 182,124 | | | | | | * | | | | | | * | | |
Niels Iverson Møller(1)
|
| | | | 4,292,604 | | | | | | 26.50 | | | | | | 4,292,604 | | | | | | 22.36 | | | | | | 21.85 | | |
Andreas Holm Mattson(2)
|
| | | | 4,163,832 | | | | | | 25.70 | | | | | | 4,163,832 | | | | | | 21.69 | | | | | | 21.19 | | |
Glenn S. Vraniak
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Directors | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Helen M. Boudreau
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Roberto Prego
|
| | | | 310,248 | | | | | | 1.92 | | | | | | 310,248 | | | | | | 1.62 | | | | | | 1.58 | | |
Steven Projan
|
| | | | 27,288 | | | | | | * | | | | | | 27,288 | | | | | | * | | | | | | * | | |
Jo Ann Suzich
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Marianne Søgaard
|
| | | | 41,652 | | | | | | * | | | | | | 41,652 | | | | | | * | | | | | | * | | |
所有現任董事和執行管理層,作為一個小組(9人)
|
| | | | 9,017,748 | | | | | | 55.67 | | | | | | 9,017,748 | | | | | | 46.97 | | | | | | 45.89 | | |
Date
|
| |
Transaction
|
| |
Share Capital
After Transaction |
| |
Price
Per share (DKK) |
| ||||||
August 2008
|
| | Formation (Nominal DKK 1) | | | | | 250,000 | | | | | | 1.00 | | |
March 2014
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 268,148 | | | | | | 120.00 | | |
December 2014
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 316,751 | | | | | | 178.22 | | |
December 2015
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 336,549 | | | | | | 435.76 | | |
March 2016
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 342,880 | | | | | | 432.12 | | |
September 2017
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 358,806 | | | | | | 1,034.75 | | |
March 2019
|
| | 轉移儲備(名義1丹麥克朗) | | | | | 717,612 | | | | | | 1.00 | | |
July 2019
|
| |
現金出資和債務轉換
(Nominal DKK 1) |
| | | | 836,994 | | | | | | 914.71(avg) | | |
December 2019
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 843,564 | | | | | | 1,037.50 | | |
September 2020
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 884,974 | | | | | | 1,002.90 | | |
October 2020
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 899,926 | | | | | | 1,008.45 | | |
January 2021
|
| | Share split 2-for-1 (Nominal DKK 1) | | | | | 899,926 | | | | | | — | | |
January 2021
|
| |
1送17(名義1丹麥克朗)紅股發行
|
| | | | 16,198,668 | | | | | | — | | |
Grant Date
|
| |
Vesting Period
|
| |
Expiration Date
|
| |
Exercise Price
|
| |
Number of Warrants
|
|
December 19, 2016
|
| |
Upon an IPO Event
|
| |
December 31, 2036
|
| |
DKK 1.0
|
| |
758,448
|
|
December 10, 2017
|
| |
Upon an IPO Event
|
| |
December 31, 2036
|
| |
DKK 1.0
|
| |
632,700
|
|
Grant Date
|
| |
Vesting Period
|
| |
Expiration Date
|
| |
Exercise Price
|
| |
Number of Warrants
|
|
December 19, 2017
|
| |
Upon an IPO Event
|
| |
December 31, 2036
|
| |
DKK 1.0
|
| |
141,804
|
|
December 17, 2020
|
| |
Upon Exit/1/36 per month
|
| |
December 31, 2036
|
| |
DKK 1.0
|
| |
757,620
|
|
未經鍛鍊即失效或作廢
|
| | | | | | | | | | |
(62,316)
|
|
| | | | | | | | | | | |
2,228,256
|
|
|
存取款人員
股票或美國存托股份持有人必須支付: |
| |
For:
|
|
$5.00 (or less) per 100 ADSs (or portion of 100 ADSs) | | |
美國存託憑證的發行,包括因股份、權利或其他財產的分配而產生的發行
為取款目的取消美國存託憑證,包括存款協議終止的情況
|
|
$.05 (or less) per ADS | | | 對美國存托股份持有者的任何現金分配 | |
如果分發給您的證券是股票,並且這些股票是為發行美國存託憑證而存放的,則應支付的費用相當於該費用 | | | 由託管人分配給美國存托股份持有人的分配給已存放證券(包括權利)持有人的證券的分配 | |
每歷年每個美國存托股份0.05美元(或更少) | | | 託管服務 | |
註冊費或轉讓費 | | | 當您存入或提取股票時,我們股票登記簿上的股票以託管人或其代理人的名義進行轉讓和登記 | |
託管人的費用 | | |
電報和傳真傳輸(如果存款協議中明確規定)
將外幣兑換成美元
|
|
託管人或託管人必須為任何美國存託憑證或股票支付的税款和其他政府費用,如股票轉讓税、印花税或預扣税 | | | As necessary | |
託管人或其代理人為已交存證券支付的任何費用 | | | As necessary | |
Underwriter
|
| |
Number of
ADSs |
| |||
Oppenheimer & Co. Inc.
|
| | | | 2,100,000 | | |
Ladenburg Thalmann & Co. Inc.
|
| | | | 900,000 | | |
Total
|
| | | | 3,000,000 | | |
| | |
Per ADS
|
| |
Total
Without Exercise of Over- Allotment Option |
| |
Total With
Full Exercise of Over- Allotment Option |
| |||||||||
Public offering price
|
| | | $ | 10.00 | | | | | $ | 30,000,000 | | | | | $ | 34,500,000 | | |
承保折扣和佣金
|
| | | $ | 0.70 | | | | | $ | 2,100,000 | | | | | $ | 2,415,000 | | |
未扣除費用的收益給我們
|
| | | $ | 9.30 | | | | | $ | 27,900,000 | | | | | $ | 32,085,000 | | |
| | 就本條文而言,就任何相關國家的任何美國存託憑證而言,“向公眾要約”一詞是指以任何形式及以任何方式就要約條款及任何擬要約的美國存託憑證向公眾傳達,以使投資者能夠決定購買或認購任何美國存託憑證,而“招股章程規例”一詞是指條例(EU)2017/1129。 | | |
| | 關於聯合王國,對《招股説明書條例》的提及包括《招股説明書條例》,因為根據《2018年歐盟(退出)法》,《招股説明書條例》是英國國內法的一部分。 | | |
Expenses
|
| |
Amount
|
| |||
SEC registration fee
|
| | | $ | 4,141 | | |
納斯達克資本市場準入和上市費
|
| | | | 55,000 | | |
FINRA filing fee
|
| | | | 5,675 | | |
印刷費和雕刻費
|
| | | | 370,000 | | |
Legal fees and expenses
|
| | | | 1,000,000 | | |
會計費和費用
|
| | | | 700,000 | | |
Miscellaneous costs
|
| | | | 60,000 | | |
Total
|
| | | $ | 2,194,816 | | |
| | |
Page
|
| |||
經審計的財務報表: | | | | | | | |
獨立註冊會計師事務所報告
|
| | | | F-2 | | |
Financial Statements:
|
| | | | | | |
截至2018年12月31日和2019年12月31日止年度的全面虧損報表
|
| | | | F-3 | | |
截至2018年1月1日和2018年12月31日及2019年12月31日的財務狀況報表
|
| | | | F-4 | | |
截至2018年和2019年12月31日止年度的權益變動表
|
| | | | F-5 | | |
截至2018年12月31日和2019年12月31日的年度現金流量表
|
| | | | F-6 | | |
財務報表附註
|
| | | | F-7 | | |
|
截至2020年和2019年9月30日的9個月未經審計的中期綜合綜合全面虧損報表
|
| | | | F-40 | | |
|
截至2020年9月30日和2019年12月31日未經審計的中期簡明財務狀況報表
|
| | | | F-41 | | |
|
前九個月未經審計的中期簡明權益變動表
Ended September 30, 2020 and 2019 |
| | | | F-42 | | |
|
截至9個月的未經審計的中期現金流量簡明合併報表
September 30, 2020 and 2019 |
| | | | F-43 | | |
|
未經審計的中期簡明合併財務報表附註
|
| | | | F-44 | | |
| | | | | |
Years Ended December 31,
|
| |||||||||
| | |
Note
|
| |
2018
|
| |
2019
|
| ||||||
| | | | | |
(單位為千美元,每股除外)
|
| |||||||||
Operating expenses: | | | | | | | | | | | | | | | | |
研發
|
| |
6
|
| | | $ | 3,729 | | | | | $ | 8,216 | | |
一般和行政
|
| |
6
|
| | | | 1,898 | | | | | | 2,647 | | |
總運營費用
|
| | | | | | | 5,627 | | | | | | 10,863 | | |
Operating loss
|
| | | | | | | (5,627) | | | | | | (10,863) | | |
Finance income
|
| |
9
|
| | | | 76 | | | | | | 65 | | |
Finance expenses
|
| |
9
|
| | | | (719) | | | | | | (1,222) | | |
Net loss before tax
|
| | | | | | | (6,270) | | | | | | (12,020) | | |
Income taxes
|
| |
10
|
| | | | 735 | | | | | | 825 | | |
Net loss for the year
|
| | | | | | $ | (5,535) | | | | | $ | (11,195) | | |
Evaxion Biotech A/S股東應佔淨虧損
|
| | | | | | $ | (5,535) | | | | | $ | (11,195) | | |
後續期間不重新分類為損益的其他全面收入(税後淨額):
|
| | | | | | | | | | | | | | | |
貨幣折算成提示貨幣的匯兑差額
|
| |
17
|
| | | | (15) | | | | | | 2 | | |
本年度其他綜合虧損,税後淨額
|
| | | | | | $ | (15) | | | | | $ | 2 | | |
全面虧損
|
| | | | | | $ | (5,550) | | | | | $ | (11,193) | | |
Evaxion Biotech A/S股東應佔全面虧損總額
|
| | | | | | $ | (5,550) | | | | | $ | (11,193) | | |
Loss per share – basic and diluted
|
| |
11
|
| | | $ | (0.43) | | | | | $ | (0.81) | | |
| | | | | |
January 1,
2018 |
| |
December 31,
|
| ||||||||||||
| | |
Note
|
| |
2018
|
| |
2019
|
| ||||||||||||
| | | | | |
(USD in thousands)
|
| |||||||||||||||
ASSETS | | | | | | | | | | | | | | | | | | | | | | |
Non-current assets | | | | | | | | | | | | | | | | | | | | | | |
財產、廠房和設備
|
| |
12
|
| | | $ | 179 | | | | | $ | 112 | | | | | $ | 101 | | |
Leasehold deposits
|
| |
16
|
| | | | 32 | | | | | | 18 | | | | | | 25 | | |
非流動資產合計
|
| | | | | | | 211 | | | | | | 130 | | | | | | 126 | | |
Current assets | | | | | | | | | | | | | | | | | | | | | | |
Receivables
|
| |
13
|
| | | | 680 | | | | | | 238 | | | | | | 575 | | |
未繳出資應收款項
|
| | | | | | | 1,129 | | | | | | – | | | | | | – | | |
Tax receivables
|
| |
10
|
| | | | 461 | | | | | | 712 | | | | | | 824 | | |
現金和現金等價物
|
| |
15
|
| | | | 468 | | | | | | 7,433 | | | | | | 9,559 | | |
Total current assets
|
| | | | | | | 2,738 | | | | | | 8,383 | | | | | | 10,958 | | |
TOTAL ASSETS
|
| | | | | | $ | 2,949 | | | | | $ | 8,513 | | | | | $ | 11,084 | | |
權益和負債 | | | | | | | | | | | | | | | | | | | | | | |
Share capital
|
| |
17
|
| | | $ | 2,113 | | | | | $ | 2,113 | | | | | $ | 2,481 | | |
Other reserves
|
| |
17
|
| | | | 3,950 | | | | | | 3,935 | | | | | | 22,693 | | |
Accumulated deficit
|
| |
17
|
| | | | (3,513) | | | | | | (6,979) | | | | | | (15,812) | | |
Total equity
|
| | | | | | | 2,550 | | | | | | (931) | | | | | | 9,362 | | |
非流動負債 | | | | | | | | | | | | | | | | | | | | | | |
Lease liabilities
|
| |
16
|
| | | | 96 | | | | | | 24 | | | | | | – | | |
非流動負債合計
|
| | | | | | | 96 | | | | | | 24 | | | | | | – | | |
流動負債 | | | | | | | | | | | | | | | | | | | | | | |
可轉換債務工具
|
| |
18
|
| | | | – | | | | | | 8,569 | | | | | | – | | |
Lease liabilities
|
| |
16
|
| | | | 66 | | | | | | 75 | | | | | | 36 | | |
Trade payables
|
| | | | | | | 59 | | | | | | 139 | | | | | | 646 | | |
Other payables
|
| |
14
|
| | | | 178 | | | | | | 637 | | | | | | 1,040 | | |
流動負債總額
|
| | | | | | | 303 | | | | | | 9,420 | | | | | | 1,722 | | |
Total liabilities
|
| | | | | | | 399 | | | | | | 9,444 | | | | | | 1,722 | | |
權益和負債合計
|
| | | | | | $ | 2,949 | | | | | $ | 8,513 | | | | | $ | 11,084 | | |
| | | | | | | | | | | |
Other reserves
|
| | | | | | | | | | | | | |||||||||
| | |
Note
|
| |
Share
capital |
| |
Share
premium |
| |
Foreign
currency translation reserve |
| |
Accumulated
deficit |
| |
Total equity
|
| |||||||||||||||
| | | | | |
(USD in thousands)
|
| |||||||||||||||||||||||||||
Equity at January 1, 2018
|
| | | | | | $ | 117 | | | | | $ | 6,102 | | | | | $ | (156) | | | | | $ | (3,513) | | | | | $ | 2,550 | | |
Bonus share issuance
|
| |
21
|
| | | | 1,996 | | | | | | (1,996) | | | | | | – | | | | | | – | | | | | | – | | |
Equity at January 1, 2018
|
| | | | | | | 2,113 | | | | | | 4,106 | | | | | | (156) | | | | | | (3,513) | | | | | | 2,550 | | |
Net loss for the year
|
| | | | | | | – | | | | | | – | | | | | | – | | | | | | (5,535) | | | | | | (5,535) | | |
其他綜合收益
|
| |
17
|
| | | | – | | | | | | – | | | | | | (15) | | | | | | – | | | | | | (15) | | |
基於股份的薪酬費用
|
| |
8
|
| | | | – | | | | | | – | | | | | | – | | | | | | 2,069 | | | | | | 2,069 | | |
Equity at December 31, 2018
|
| | | | | | $ | 2,113 | | | | | $ | 4,106 | | | | | $ | (171) | | | | | $ | (6,979) | | | | | $ | (931) | | |
Net loss for the year
|
| | | | | | | – | | | | | | – | | | | | | – | | | | | | (11,195) | | | | | | (11,195) | | |
其他綜合收益
|
| |
17
|
| | | | – | | | | | | – | | | | | | 2 | | | | | | – | | | | | | 2 | | |
基於股份的薪酬費用
|
| |
8
|
| | | | – | | | | | | – | | | | | | – | | | | | | 2,362 | | | | | | 2,362 | | |
發行股票換取現金
|
| |
17
|
| | | | 181 | | | | | | 9,261 | | | | | | – | | | | | | – | | | | | | 9,442 | | |
Transaction costs
|
| |
17
|
| | | | – | | | | | | (13) | | | | | | – | | | | | | – | | | | | | (13) | | |
可轉換債務工具結算
|
| |
18
|
| | | | 187 | | | | | | 9,508 | | | | | | – | | | | | | – | | | | | | 9,695 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Equity at December 31, 2019
|
| | | | | | $ | 2,481 | | | | | $ | 22,862 | | | | | $ | (169) | | | | | $ | (15,812) | | | | | $ | 9,362 | | |
| | | | | |
Years Ended December 31,
|
| |||||||||
| | |
Note
|
| |
2018
|
| |
2019
|
| ||||||
| | | | | |
(USD in thousands)
|
| |||||||||
經營活動: | | | | | | | | | | | | | | | | |
Net loss for the year
|
| | | | | | $ | (5,535) | | | | | $ | (11,195) | | |
非現金項目調整
|
| |
15
|
| | | | 2,123 | | | | | | 2,945 | | |
非流動金融資產 - 租賃存款變動
|
| | | | | | | 13 | | | | | | (7) | | |
Interest received
|
| | | | | | | 2 | | | | | | 9 | | |
Interest paid
|
| | | | | | | (15) | | | | | | (39) | | |
Income taxes received
|
| | | | | | | 453 | | | | | | 688 | | |
營運資金變動前的經營活動現金流
|
| | | | | | | (2,959) | | | | | | (7,599) | | |
營運資金變動產生的現金流: | | | | | | | | | | | | | | | | |
淨營運資金變動
|
| |
15
|
| | | | 981 | | | | | | 573 | | |
經營活動中使用的淨現金
|
| | | | | | | (1,978) | | | | | | (7,026) | | |
投資活動: | | | | | | | | | | | | | | | | |
購置房產、廠房和設備
|
| |
12
|
| | | | (7) | | | | | | (61) | | |
投資活動中使用的淨現金
|
| | | | | | | (7) | | | | | | (61) | | |
融資活動: | | | | | | | | | | | | | | | | |
股票發行收益
|
| |
17
|
| | | | 1,092 | | | | | | 9,442 | | |
與發行股票相關的交易成本
|
| | | | | | | – | | | | | | (13) | | |
發行可轉換債務工具所得收益
|
| |
15
|
| | | | 7,998 | | | | | | 152 | | |
Leasing installments
|
| |
15, 16
|
| | | | (63) | | | | | | (73) | | |
融資活動提供的現金淨額
|
| | | | | | | 9,027 | | | | | | 9,508 | | |
現金和現金等價物淨增長
|
| | | | | | | 7,042 | | | | | | 2,421 | | |
年初現金和現金等價物
|
| |
15
|
| | | | 468 | | | | | | 7,433 | | |
現金和現金等價物的匯率調整
|
| | | | | | | (77) | | | | | | (295) | | |
現金和現金等價物,年終
|
| |
15
|
| | | $ | 7,433 | | | | | $ | 9,559 | | |
Assets
|
| |
Useful life
|
|
Properties | | | 資產的租賃期限和使用壽命較短 | |
Other equipment | | | 3 – 6 years | |
| | |
Ref.
|
| |
As most recently
reported at January 1, 2018 (Local GAAP) |
| |
IFRS
conversion |
| |
As adjusted at
January 1, 2018 (IFRS) |
| ||||||||||||
| | | | | | | | |
(USD in thousands)
|
| |||||||||||||||
ASSETS | | | | | | | | | | | | | | | | | | | | | | | | | |
財產、廠房和設備
|
| | | | 1 | | | | | $ | 21 | | | | | $ | 158 | | | | | $ | 179 | | |
Leasehold deposits
|
| | | | | | | | | | 32 | | | | | | – | | | | | | 32 | | |
非流動資產合計 | | | | | | | | | | | 53 | | | | | | 158 | | | | | | 211 | | |
Receivables
|
| | | | | | | | | | 680 | | | | | | – | | | | | | 680 | | |
未繳出資應收款項
|
| | | | | | | | | | 1,129 | | | | | | – | | | | | | 1,129 | | |
Tax receivables
|
| | | | | | | | | | 461 | | | | | | – | | | | | | 461 | | |
現金和現金等價物
|
| | | | | | | | | | 468 | | | | | | – | | | | | | 468 | | |
Total current assets
|
| | | | | | | | | | 2,738 | | | | | | – | | | | | | 2,738 | | |
TOTAL ASSETS
|
| | | | | | | | | $ | 2,791 | | | | | $ | 158 | | | | | $ | 2,949 | | |
權益和負債 | | | | | | | | | | | | | | | | | | | | | | | | | |
Share capital
|
| | | | | | | | | $ | 117 | | | | | $ | – | | | | | $ | 117 | | |
Other reserves
|
| | | | | | | | | | 5,946 | | | | | | – | | | | | | 5,946 | | |
Accumulated deficit
|
| | | | 1 | | | | | | (3,509) | | | | | | (4) | | | | | | (3,513) | | |
Total equity
|
| | | | | | | | | | 2,554 | | | | | | (4) | | | | | | 2,550 | | |
Lease liabilities
|
| | | | 1 | | | | | | – | | | | | | 96 | | | | | | 96 | | |
Total current assets
|
| | | | | | | | | | – | | | | | | 96 | | | | | | 96 | | |
Lease liabilities
|
| | | | 1 | | | | | | – | | | | | | 66 | | | | | | 66 | | |
Trade payables
|
| | | | | | | | | | 59 | | | | | | – | | | | | | 59 | | |
Other payables
|
| | | | | | | | | | 178 | | | | | | – | | | | | | 178 | | |
流動負債總額
|
| | | | | | | | | | 237 | | | | | | 66 | | | | | | 303 | | |
Total liabilities
|
| | | | | | | | | | 237 | | | | | | 162 | | | | | | 399 | | |
權益和負債合計
|
| | | | | | | | | $ | 2,791 | | | | | $ | 158 | | | | | $ | 2,949 | | |
| | |
Ref.
|
| |
As most recently
reported at December 31, 2018 (Local GAAP) |
| |
IFRS
conversion |
| |
As adjusted at
December 31, 2018 (IFRS) |
| |||||||||
| | | | | |
(USD in thousands)
|
| |||||||||||||||
ASSETS | | | | | | | | | | | | | | | | | | | | | | |
財產、廠房和設備
|
| |
1
|
| | | $ | 20 | | | | | $ | 92 | | | | | $ | 112 | | |
Leasehold deposits
|
| | | | | | | 18 | | | | | | – | | | | | | 18 | | |
非流動資產合計
|
| | | | | | | 38 | | | | | | 92 | | | | | | 130 | | |
Receivables | | | | | | | | 238 | | | | | | – | | | | | | 238 | | |
Tax receivables
|
| | | | | | | 712 | | | | | | – | | | | | | 712 | | |
現金和現金等價物
|
| | | | | | | 7,433 | | | | | | – | | | | | | 7,433 | | |
Total current assets
|
| | | | | |
|
8,383
|
| | | | | – | | | | |
|
8,383
|
| |
TOTAL ASSETS
|
| | | | | | $ | 8,421 | | | | | $ | 92 | | | | | $ | 8,513 | | |
|
| | |
Ref.
|
| |
As most recently
reported at December 31, 2018 (Local GAAP) |
| |
IFRS
conversion |
| |
As adjusted at
December 31, 2018 (IFRS) |
| |||||||||
| | | | | |
(USD in thousands)
|
| |||||||||||||||
權益和負債 | | | | | | | | | | | | | | | | | | | | | | |
Share capital
|
| | | | | | $ | 2,113 | | | | | $ | – | | | | | $ | 2,113 | | |
Other reserves
|
| |
2
|
| | | | 9,930 | | | | | | (5,995) | | | | | | 3,935 | | |
Accumulated deficit
|
| |
1, 2, 3
|
| | | | (6,300) | | | | | | (679) | | | | | | (6,979) | | |
Total equity
|
| | | | | | | 5,743 | | | | | | (6,674) | | | | | | (931) | | |
Lease liabilities
|
| | | | | | | – | | | | | | 24 | | | | | | 24 | | |
非流動負債合計
|
| |
1
|
| | | | – | | | | |
|
24
|
| | | |
|
24
|
| |
可轉換債務工具
|
| |
2
|
| | | | 1,902 | | | | | | 6,667 | | | | | | 8,569 | | |
Lease liabilities
|
| |
1
|
| | | | – | | | | | | 75 | | | | | | 75 | | |
Trade payables
|
| | | | | | | 139 | | | | | | – | | | | | | 139 | | |
Other payables
|
| | | | | | | 637 | | | | | | – | | | | | | 637 | | |
流動負債總額
|
| | | | | | | 2,678 | | | | | | 6,742 | | | | | | 9,420 | | |
Total liabilities
|
| | | | | | | 2,678 | | | | | | 6,766 | | | | | | 9,444 | | |
權益和負債合計
|
| | | | | | $ | 8,421 | | | | | $ | 92 | | | | | $ | 8,513 | | |
|
| | |
Ref.
|
| |
As most recently
reported for the year ended December 31, 2018 (Local GAAP) |
| |
IFRS
conversion |
| |
As adjusted for
the year ended December 31, 2018 (IFRS) |
| | | |||||||||||||
| | | | | |
(USD in thousands)
|
| | | | | | | |||||||||||||||
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | ||||
Gross loss
|
| |
4
|
| | | $ | (1,592) | | | | | $ | 1,592 | | | | | $ | – | | | | | ||||
Staff costs
|
| |
4
|
| | | | (1,956) | | | | | | 1,956 | | | | | | – | | | | | ||||
折舊、攤銷和減值損失
|
| |
4
|
| | | | (10) | | | | | | 10 | | | | | | – | | | | | ||||
研發
|
| |
3, 4
|
| | | | – | | | | | | (3,729) | | | | | | (3,729) | | | | | ||||
一般和行政
|
| |
3, 4
|
| | | | – | | | | | | (1,898) | | | | | | (1,898) | | | | | ||||
Operating loss
|
| | | | | | | (3,558) | | | | | | (2,069) | | | | | | (5,627) | | | | | ||||
Financial income
|
| | | | | | | 76 | | | | | | – | | | | | | 76 | | | | | ||||
Financial expenses
|
| |
1, 2
|
| | | | (107) | | | | | | (612) | | | | | | (719) | | | | | ||||
Net loss before tax
|
| | | | | | | (3,589) | | | | | | (2,681) | | | | | | (6,270) | | | | | ||||
Income tax
|
| | | | | | | 735 | | | | | | – | | | | | | 735 | | | | | ||||
Net loss for the year
|
| | | | | | $ | (2,854) | | | | | $ | (2,681) | | | | | $ | (5,535) | | | | | ||||
Evaxion股東應佔淨虧損
Biotech A/S |
| | | | | | $ | (2,854) | | | | | $ | (2,681) | | | | | $ | (5,535) | | | | | ||||
|
| | |
Ref.
|
| |
As most recently
reported for the year ended December 31, 2018 (Local GAAP) |
| |
IFRS
conversion |
| |
As adjusted for
the year ended December 31, 2018 (IFRS) |
| | | |||||||||||||
| | | | | |
(USD in thousands)
|
| | | | | | | |||||||||||||||
後續期間不重新分類為損益的其他全面收入(税後淨額):
|
| | | | | | | | | | | | | | | | | | | | | | | | ||||
貨幣折算成提示貨幣的匯兑差額
|
| | | | | | | 68 | | | | | | (83) | | | | | | (15) | | | | | ||||
全面虧損
|
| | | | | | $ | (2,786) | | | | | $ | (2,764) | | | | | $ | (5,550) | | | | | ||||
Evaxion Biotech A/S股東應佔全面虧損總額
|
| | | | | | $ | (2,786) | | | | | $ | (2,764) | | | | | $ | (5,550) | | | | | ||||
|
| | |
January 1, 2018
|
| |||||||||||||||||||||||||||||||||
(USD in thousands)
|
| |
Carrying
amount |
| |
Contractual
cash flows |
| |
year
|
| |
1 – 5
years |
| |
>5
years |
| |
Total
|
| ||||||||||||||||||
Lease liabilities
|
| | | $ | 162 | | | | | $ | 198 | | | | | $ | 68 | | | | | $ | 130 | | | | | $ | – | | | | | $ | 198 | | |
Trade payables
|
| | | | 59 | | | | | | 59 | | | | | | 59 | | | | | | – | | | | | | – | | | | | | 59 | | |
Other payables
|
| | | | 19 | | | | | | 19 | | | | | | 19 | | | | | | – | | | | | | – | | | | | | 19 | | |
Total
|
| | | $ | 240 | | | | | $ | 276 | | | | | $ | 146 | | | | | $ | 130 | | | | | $ | – | | | | | $ | 276 | | |
|
| | |
December 31, 2018
|
| |||||||||||||||||||||||||||||||||
(USD in thousands)
|
| |
Carrying
amount |
| |
Contractual
cash flows |
| |
year
|
| |
1 – 5
years |
| |
>5
years |
| |
Total
|
| ||||||||||||||||||
可轉換債務工具(1)
|
| | | $ | 8,569 | | | | | $ | 2,132 | | | | | $ | 2,132 | | | | | $ | — | | | | | $ | — | | | | | $ | 2,132 | | |
Lease liabilities
|
| | | | 99 | | | | | | 130 | | | | | | 75 | | | | | | 55 | | | | | | | | | | | | 130 | | |
Trade payables
|
| | | | 139 | | | | | | 139 | | | | | | 139 | | | | | | — | | | | | | — | | | | | | 139 | | |
Other payables
|
| | | | 214 | | | | | | 214 | | | | | | 214 | | | | | | — | | | | | | — | | | | | | 214 | | |
Total
|
| | | $ | 9,021 | | | | | $ | 2,615 | | | | | $ | 2,560 | | | | | $ | 55 | | | | | $ | — | | | | | $ | 2,615 | | |
| | |
December 31, 2019
|
| |||||||||||||||||||||||||||||||||
(USD in thousands)
|
| |
Carrying
amount |
| |
Contractual
cash flows |
| |
year
|
| |
1 – 5
years |
| |
>5
years |
| |
Total
|
| ||||||||||||||||||
Lease liabilities
|
| | | $ | 36 | | | | | $ | 55 | | | | | $ | 55 | | | | | $ | — | | | | | $ | — | | | | | $ | 55 | | |
Trade payables
|
| | | | 646 | | | | | | 646 | | | | | | 646 | | | | | | — | | | | | | — | | | | | | 646 | | |
Other payables
|
| | | | 177 | | | | | | 177 | | | | | | 177 | | | | | | — | | | | | | — | | | | | | 177 | | |
Total
|
| | | $ | 859 | | | | | $ | 878 | | | | | $ | 878 | | | | | $ | — | | | | | $ | — | | | | | $ | 878 | | |
| | |
December 31, 2018
|
| |||||||||||||||||||||
(USD in thousands)
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Aggregate
Fair Value |
| ||||||||||||
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
可轉換債務工具
|
| | | $ | – | | | | | $ | – | | | | | $ | 8,569 | | | | | $ | 8,569 | | |
Total liabilities
|
| | | $ | – | | | | | $ | – | | | | | $ | 8,569 | | | | | $ | 8,569 | | |
| | |
Years Ended
December 31, |
| |||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||
員工工資和福利支出,不包括基於股份的薪酬
|
| | | $ | (1,756) | | | | | $ | (2,586) | | |
基於股份的薪酬費用
|
| | | | (896) | | | | | | (1,021) | | |
Depreciation
|
| | | | (59) | | | | | | (65) | | |
External expenses
|
| | | | (1,018) | | | | | | (4,544) | | |
研發費用總額
|
| | | $ | (3,729) | | | | | $ | (8,216) | | |
| | |
Years Ended
December 31, |
| |||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||
員工工資和福利支出,不包括基於股份的薪酬
|
| | | $ | (190) | | | | | $ | (517) | | |
基於股份的薪酬費用
|
| | | | (1,173) | | | | | | (1,341) | | |
Professional fees
|
| | | | (520) | | | | | | (773) | | |
Depreciation
|
| | | | (15) | | | | | | (16) | | |
一般和行政費用合計
|
| | | $ | (1,898) | | | | | $ | (2,647) | | |
| | |
Years Ended
December 31, |
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
全職員工平均人數
|
| | | | 18 | | | | | | 25 | | |
期末按國家分列的僱員(包括顧問)人數: | | | | | | | | | | | | | |
Denmark
|
| | | | 20 | | | | | | 36 | | |
期末包括顧問在內的員工總數
|
| | | | 20 | | | | | | 36 | | |
|
| | |
Years Ended
December 31, |
| |||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||
Wages and salaries
|
| | | $ | 1,733 | | | | | $ | 2,819 | | |
基於股份的薪酬費用
|
| | | | 2,069 | | | | | | 2,362 | | |
已定義的繳費計劃
|
| | | | 70 | | | | | | 96 | | |
其他社會保障費用
|
| | | | 10 | | | | | | 12 | | |
Other staff expenses
|
| | | | 133 | | | | | | 176 | | |
Total
|
| | | $ | 4,015 | | | | | $ | 5,465 | | |
|
| | |
Years Ended
December 31, |
| |||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||
員工總成本分類為: | | | | | | | | | | | | | |
研發費用
|
| | | $ | 2,652 | | | | | $ | 3,607 | | |
一般和行政費用
|
| | | | 1,363 | | | | | | 1,858 | | |
Total
|
| | | $ | 4,015 | | | | | $ | 5,465 | | |
|
| | |
Years Ended
December 31, |
| |||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||
非管理層員工福利支出分類為: | | | | | | | | | | | | | |
研發費用
|
| | | $ | 1,686 | | | | | $ | 2,590 | | |
一般和行政費用
|
| | | | 26 | | | | | | 668 | | |
Total
|
| | | $ | 1,712 | | | | | $ | 3,258 | | |
| | |
Year Ended
December 31, |
| |||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||
高管薪酬: | | | | | | | | | | | | | |
Wages and salaries
|
| | | $ | 621 | | | | | $ | 900 | | |
基於股份的薪酬費用
|
| | | | 1,157 | | | | | | 956 | | |
Total
|
| | | | 1,778 | | | | | | 1,856 | | |
董事會薪酬: | | | | | | | | | | | | | |
基於股份的薪酬費用
|
| | | | 525 | | | | | | 351 | | |
Total
|
| | | | 525 | | | | | | 351 | | |
董事會和執行管理層的薪酬分類為:
|
| | | | | | | | | | | | |
研發費用
|
| | | | 965 | | | | | | 1,017 | | |
一般和行政費用
|
| | | | 1,338 | | | | | | 1,190 | | |
Total
|
| | | $ | 2,303 | | | | | $ | 2,207 | | |
|
| | |
Number
of warrants |
| |
Weighted
Average Exercise Price/Share (DKK) |
| |
Weighted
Average Remaining Contractual Life (years) |
| ||||||
Warrants granted as at January 1, 2018*
|
| | | | 1,481,796 | | | |
DKK 1
|
| | | | 19 | | |
Warrants granted**
|
| | | | 192,528 | | | |
1
|
| | | | 18 | | |
Warrants granted as at December 31, 2018
|
| | | | 1,674,324 | | | |
1
|
| | | | 18 | | |
Warrants granted**
|
| | | | 257,832 | | | |
1
|
| | | | 17 | | |
Warrants granted as at December 31, 2019
|
| | | | 1,932,156 | | | |
DKK 1
|
| | | | 17 | | |
於2018年12月31日可行使的認股權證
|
| | | | – | | | |
DKK 1
|
| | | | – | | |
於2019年12月31日可行使的認股權證
|
| | | | – | | | |
DKK 1
|
| | | | – | | |
Participants
|
| |
Number of
warrants |
| |
Estimated
fair value |
| |
Vesting Term
|
| |
Exercise Price
(DKK) |
| |||||||||
Employees
|
| | | | 63,360 | | | | | $ | 60萬 | | | |
3 years
|
| | | | 1 | | |
科學顧問委員會
|
| | | | 22,860 | | | | | $ | 20萬 | | | |
Immediate
|
| | | | 1 | | |
Board of Directors
|
| | | | 40,752 | | | | | $ | 40萬 | | | |
Immediate
|
| | | | 1 | | |
| | |
Years Ended
December 31, |
| | |||||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| | ||||||||
研發費用
|
| | | $ | 896 | | | | | $ | 1,021 | | | | ||
一般和行政費用
|
| | | | 1,173 | | | | | | 1,341 | | | | ||
Total
|
| | | $ | 2,069 | | | | | $ | 2,362 | | | | | |
Outstanding program
|
| |
Per warrant
weighted average grant date fair value (DKK) |
| |
Number of
warrants outstanding |
| |
Average
exercise price per warrant (DKK) |
| |
Remaining
term to maturity (years) |
| ||||||||||||
Grant (December 2016)
|
| | | | 20.91 | | | | | | 712,332 | | | | | | 1 | | | | | | 18 | | |
Grant (April 2017)
|
| | | | 24.05 | | | | | | 13,896 | | | | | | 1 | | | | | | 18 | | |
Grant (September 2017)
|
| | | | 28.71 | | | | | | 617,184 | | | | | | 1 | | | | | | 18 | | |
Grant (December 2017)
|
| | | | 28.71 | | | | | | 138,384 | | | | | | 1 | | | | | | 18 | | |
Granted (during 2018)**
|
| | | | 37.05 | | | | | | 192,528 | | | | | | 1 | | | | | | 18 | | |
Granted at December 31, 2018
|
| | | | | | | | | | 1,674,324 | | | | | | 1 | | | | | | 18 | | |
可於2018年12月31日執行的認股權證
|
| | | | | | | | | | – | | | | | | 1 | | | | | | 17 | | |
|
Outstanding program
|
| |
Per warrant
weighted average grant date fair value (DKK) |
| |
Number of
warrants outstanding |
| |
Average
exercise price per warrant (DKK) |
| |
Remaining
term to maturity (years) |
| ||||||||||||
Grant (December 2016)
|
| | | | 20.91 | | | | | | 712,332 | | | | | | 1 | | | | | | 17 | | |
Grant (April 2017)
|
| | | | 24.05 | | | | | | 13,896 | | | | | | 1 | | | | | | 17 | | |
Grant (September 2017)
|
| | | | 28.71 | | | | | | 617,184 | | | | | | 1 | | | | | | 17 | | |
Grant (December 2017)
|
| | | | 28.71 | | | | | | 138,384 | | | | | | 1 | | | | | | 17 | | |
Grant (during 2018)(1)**
|
| | | | 37.05 | | | | | | 192,528 | | | | | | 1 | | | | | | 17 | | |
Grant (January 2019)(1)**
|
| | | | 37.05 | | | | | | 45,216 | | | | | | 1 | | | | | | 17 | | |
Grant (February 2019)**
|
| | | | 42.57 | | | | | | 7,956 | | | | | | 1 | | | | | | 17 | | |
Grant (September 2019)**
|
| | | | 56.35 | | | | | | 54,000 | | | | | | 1 | | | | | | 17 | | |
Grant (October 2019)**
|
| | | | 56.97 | | | | | | 150,660 | | | | | | 1 | | | | | | 17 | | |
Granted at December 31, 2019
|
| | | | | | | | | | 1,932,156 | | | | | | 1 | | | | | | 17 | | |
可於2019年12月31日起行使的認股權證
|
| | | | | | | | | | – | | | | | | 1 | | | | | | 17 | | |
Number of warrants held
|
| |
January 1,
2018 |
| |
Granted**
|
| |
December 31,
2018 |
| |
Granted**
|
| |
December 31,
2019 |
| |||||||||||||||
Thomas William Wylonis
|
| | | | 293,364 | | | | | | 49,248 | | | | | | 342,612 | | | | | | – | | | | | | 342,612 | | |
Steven Projan
|
| | | | – | | | | | | 23,436 | | | | | | 23,436 | | | | | | – | | | | | | 23,436 | | |
Roberto Prego
|
| | | | 7,416 | | | | | | 12,384 | | | | | | 19,800 | | | | | | – | | | | | | 19,800 | | |
Roberto Prego Novo (former)
|
| | | | 115,092 | | | | | | 4,356 | | | | | | 119,448 | | | | | | – | | | | | | 119,448 | | |
Joann Suzich
|
| | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | – | | |
董事會總數
|
| | | | 415,872 | | | | | | 89,424 | | | | | | 505,296 | | | | | | – | | | | | | 505,296 | | |
Lars Aage Staal Wegner
|
| | | | 840,528 | | | | | | 3,888 | | | | | | 844,416 | | | | | | – | | | | | | 844,416 | | |
Thomas Bogenrieder
|
| | | | 4,356 | | | | | | – | | | | | | 4,356 | | | | | | 45,216 | | | | | | 49,572 | | |
Glenn S. Vraniak
|
| | | | – | | | | | | – | | | | | | – | | | | | | 150,660 | | | | | | 150,660 | | |
高管管理合計
|
| | | | 844,884 | | | | | | 3,888 | | | | | | 848,772 | | | | | | 195,876 | | | | | | 1,044,648 | | |
| | |
Years Ended
December 31, |
| |||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||
Finance income: | | | | | | | | | | | | | |
Interest income, bank
|
| | | $ | 2 | | | | | $ | 8 | | |
Interest income, other
|
| | | | – | | | | | | 1 | | |
Foreign exchange gains
|
| | | | 74 | | | | | | 56 | | |
Total financial income
|
| | | | 76 | | | | | | 65 | | |
Finance expenses: | | | | | | | | | | | | | |
Interest expenses
|
| | | | (10) | | | | | | (36) | | |
可轉換債務工具公允價值變動
|
| | | | (684) | | | | | | (1,183) | | |
利息支出、租賃負債
|
| | | | (4) | | | | | | (3) | | |
匯兑損失
|
| | | | (21) | | | | | | – | | |
財務費用總額
|
| | | | (719) | | | | | | (1,222) | | |
Net financial items
|
| | | $ | (643) | | | | | $ | (1,157) | | |
| | |
Years Ended
December 31, |
| |||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||
Income taxes
|
| | | $ | (735) | | | | | $ | (825) | | |
本年度所得税總額
|
| | | $ | (735) | | | | | $ | (825) | | |
| | |
Years Ended December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
丹麥法定企業所得税税率
|
| | | | 22% | | | | | | 22% | | |
不可扣除的費用
|
| | | | (10)% | | | | | | (5)% | | |
税收抵免研發支出
|
| | | | 12% | | | | | | 7% | | |
未資本化的遞延税項資產變動
|
| | | | (12)% | | | | | | (17)% | | |
Total effective tax rate
|
| | | | 12% | | | | | | 7% | | |
| | |
December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
遞延納税頭寸 | | | | | | | | | | | | | |
Warrants
|
| | | $ | 1,463 | | | | | $ | 3,034 | | |
Loss carry forward
|
| | | | 136 | | | | | | 1,270 | | |
Other items
|
| | | | 48 | | | | | | (34) | | |
遞延税項資產計價準備
|
| | | | (1,647) | | | | | | (4,270) | | |
未確認遞延税金負債總額
|
| | | $ | – | | | | | $ | – | | |
| | |
Years Ended December 31,
|
| |||||||||
(美元以千為單位,不包括每股金額和每股金額)
|
| |
2018
|
| |
2019
|
| ||||||
稀釋前後每股虧損 | | | | | | | | | | | | | |
Evaxion Biotech A/S股東應佔淨虧損
|
| | | $ | (5,535) | | | | | $ | (11,195) | | |
加權平均已發行普通股數量
|
| | | | 12,917,016 | | | | | | 13,892,314 | | |
稀釋前後每股虧損
|
| | | $ | (0.43) | | | | | $ | (0.81) | | |
| | |
December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
Warrants
|
| | | | 1,674,324 | | | | | | 2,059,128 | | |
Convertible Debt l
|
| | | | 302,976 | | | | | | – | | |
Convertible Debt 2
|
| | | | 827,856 | | | | | | – | | |
(USD in thousands)
|
| |
Property
|
| |
Other
Equipment |
| |
Total
|
| |||||||||
Cost at January 1, 2018
|
| | | $ | 172 | | | | | $ | 27 | | | | | $ | 199 | | |
本年度新增數量
|
| | | | 7 | | | | | | 7 | | | | | | 14 | | |
匯率調整
|
| | | | (8) | | | | | | (2) | | | | | | (10) | | |
Cost at December 31, 2018
|
| | | | 171 | | | | | | 32 | | | | | | 203 | | |
Depreciation at January 1, 2018
|
| | | | (12) | | | | | | (6) | | | | | | (18) | | |
本年度折舊
|
| | | | (70) | | | | | | (7) | | | | | | (77) | | |
匯率調整
|
| | | | 3 | | | | | | 1 | | | | | | 4 | | |
Depreciation at December 31, 2018
|
| | | | (79) | | | | | | (12) | | | | | | (91) | | |
Carrying amount at December 31, 2018
|
| | | $ | 92 | | | | | $ | 20 | | | | | $ | 112 | | |
2018年12月31日使用權資產賬面金額
|
| | | $ | 92 | | | | | $ | – | | | | | $ | 92 | | |
| | | | | | | | | | | | | | | | | | | |
(USD in thousands)
|
| |
Property
|
| |
Other
Equipment |
| |
Total
|
| |||||||||
Cost at December 31, 2018
|
| | | $ | 171 | | | | | $ | 32 | | | | | $ | 203 | | |
本年度新增數量
|
| | | | 12 | | | | | | 61 | | | | | | 73 | | |
匯率調整
|
| | | | (4) | | | | | | – | | | | | | (4) | | |
Cost at December 31, 2019
|
| | | | 179 | | | | | | 93 | | | | | | 272 | | |
Depreciation at December 31, 2018
|
| | | | (79) | | | | | | (13) | | | | | | (92) | | |
本年度折舊
|
| | | | (67) | | | | | | (14) | | | | | | (81) | | |
匯率調整
|
| | | | 2 | | | | | | – | | | | | | 2 | | |
Depreciation at December 31, 2019
|
| | | | (144) | | | | | | (27) | | | | | | (171) | | |
Carrying amount at December 31, 2019
|
| | | $ | 35 | | | | | $ | 66 | | | | | $ | 101 | | |
2019年12月31日使用權資產賬面金額
|
| | | $ | 35 | | | | | $ | – | | | | | $ | 35 | | |
| | |
Years Ended
December 31, |
| |||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||
研發
|
| | | $ | 58 | | | | | $ | 64 | | |
一般和行政
|
| | | | 15 | | | | | | 16 | | |
全面損失表中包含的折舊總額
|
| | | $ | 73 | | | | | $ | 80 | | |
12月31日使用權資產累計折舊總額
|
| | | $ | 79 | | | | | $ | 145 | | |
| | |
January 1,
2018 |
| |
December 31,
|
| ||||||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||||||||
VAT receivables
|
| | | $ | 26 | | | | | $ | 55 | | | | | $ | 75 | | |
Prepayments
|
| | | | – | | | | | | 148 | | | | | | 451 | | |
向臨牀研究機構預付款項
|
| | | | 133 | | | | | | 30 | | | | | | 17 | | |
協作夥伴應收賬款
|
| | | | 516 | | | | | | – | | | | | | – | | |
Other receivables
|
| | | | 5 | | | | | | 5 | | | | | | 32 | | |
Total receivables
|
| | | $ | 680 | | | | | $ | 238 | | | | | $ | 575 | | |
| | |
January 1,
2018 |
| |
December 31,
|
| ||||||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||||||||
支付給臨牀研究機構的款項
|
| | | $ | – | | | | | $ | 197 | | | | | $ | 588 | | |
員工成本負債
|
| | | | 159 | | | | | | 226 | | | | | | 275 | | |
Other liabilities
|
| | | | 19 | | | | | | 214 | | | | | | 177 | | |
Total other payables
|
| | | $ | 178 | | | | | $ | 637 | | | | | $ | 1,040 | | |
| | |
January 1,
2018 |
| |
December 31,
|
| ||||||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||||||||
現金和現金等價物
|
| | | $ | 468 | | | | | $ | 7,433 | | | | | $ | 9,559 | | |
現金和現金等價物合計
|
| | | $ | 468 | | | | | $ | 7,433 | | | | | $ | 9,559 | | |
| | |
December 31,
|
| |||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||
Changes in receivables
|
| | | $ | 443 | | | | | $ | (337) | | |
貿易應付款變更
|
| | | | 79 | | | | | | 507 | | |
其他應付款的更改
|
| | | | 459 | | | | | | 403 | | |
淨營運資金變動
|
| | | $ | 981 | | | | | $ | 573 | | |
| | |
Years ended
December 31, |
| |||||||||
(USD in thousands)
|
| |
2018
|
| |
2019
|
| ||||||
Income taxes
|
| | | $ | (735) | | | | | $ | (825) | | |
Depreciation
|
| | | | 74 | | | | | | 81 | | |
Interest income
|
| | | | (2) | | | | | | (9) | | |
Interest expense
|
| | | | 15 | | | | | | 39 | | |
基於股份的薪酬費用
|
| | | | 2,069 | | | | | | 2,362 | | |
可轉換債務工具公允價值變動
|
| | | | 684 | | | | | | 1,183 | | |
Other adjustments:
其他調整,主要是匯率調整 |
| | | | 18 | | | | | | 114 | | |
非現金項目調整合計
|
| | | $ | 2,123 | | | | | $ | 2,945 | | |
|
(USD in thousands)
|
| |
January 1,
2018 |
| |
Cash flows
|
| |
Accumulated
interest |
| |
Fair value
Adjustment |
| |
Additions
|
| |
Conversion
|
| |
Exchange
rate adjustment |
| |
December 31,
2018 |
| ||||||||||||||||||||||||
Lease liabilities
|
| | | $ | 162 | | | | | $ | (67) | | | | | $ | 5 | | | | | $ | – | | | | | $ | 7 | | | | | $ | – | | | | | $ | (8) | | | | | $ | 99 | | |
可轉換債務工具
|
| | | | – | | | | | | 7,998 | | | | | | – | | | | | | 684 | | | | | | – | | | | | | – | | | | | | (113) | | | | | | 8,569 | | |
Total liabilities
from financing activities |
| | | $ | 162 | | | | | $ | 7,931 | | | | | $ | 5 | | | | | $ | 684 | | | | | $ | 7 | | | | | $ | – | | | | | $ | (121) | | | | | $ | 8,668 | | |
|
(USD in thousands)
|
| |
December 31,
2018 |
| |
Cash flows
|
| |
Accumulated
interest |
| |
Fair value
adjustment |
| |
Additions
|
| |
Conversion
|
| |
Exchange
rate adjustment |
| |
December 31,
2019 |
| ||||||||||||||||||||||||
Lease liabilities
|
| | | $ | 99 | | | | | $ | (75) | | | | | $ | 2 | | | | | $ | – | | | | | $ | 12 | | | | | $ | – | | | | | $ | (2) | | | | | $ | 36 | | |
可轉換債務工具
|
| | | | 8,569 | | | | | | 152 | | | | | | – | | | | | | 1,183 | | | | | | – | | | | | | (9,695) | | | | | | (209) | | | | | | – | | |
Total liabilities
from financing activities |
| | | $ | 8,668 | | | | | $ | 77 | | | | | $ | 2 | | | | | $ | 1,183 | | | | | $ | 12 | | | | | $ | (9,695) | | | | | $ | (211) | | | | | $ | 36 | | |
(USD in thousands)
|
| |
Right-of-Use Asset
|
| |
Lease liabilities
|
| ||||||
At January 1, 2018
|
| | | $ | 160 | | | | | $ | 162 | | |
Additions
|
| | | | 7 | | | | | | 7 | | |
Depreciation
|
| | | | (70) | | | | | | – | | |
Interest Expense
|
| | | | – | | | | | | 5 | | |
Payments
|
| | | | – | | | | | | (67) | | |
Translation
|
| | | | (5) | | | | | | (8) | | |
At December 31, 2018
|
| | | $ | 92 | | | | | $ | 99 | | |
|
(USD in thousands)
|
| |
Right-of-Use Asset
|
| |
Lease liabilities
|
| ||||||
At December 31, 2018
|
| | | | 92 | | | | | | 99 | | |
Additions
|
| | | | 12 | | | | | | 12 | | |
Depreciation
|
| | | | (67) | | | | | | – | | |
Interest Expense
|
| | | | – | | | | | | 2 | | |
Payments
|
| | | | – | | | | | | (75) | | |
Translation
|
| | | | (2) | | | | | | (2) | | |
At December 31, 2019
|
| | | | 35 | | | | | | 36 | | |
| | |
Number of
Ordinary Shares |
| |
Share Capital
(DKK in thousands) |
| ||||||
Share capital, January 1, 2018
|
| | | | 12,917,016 | | | | | | 12,917 | | |
Share capital, December 31, 2018
|
| | | | 12,917,016 | | | | | | 12,917 | | |
2019年7月17日增資(發行股票換現金)
|
| | | | 997,668 | | | | | | 998 | | |
2019年7月17日增資(可轉債轉換1)
|
| | | | 302,976 | | | | | | 303 | | |
2019年7月17日增資(可轉債轉換2)
|
| | | | 848,232 | | | | | | 848 | | |
2019年12月19日增資(發行股票換現金)
|
| | | | 118,260 | | | | | | 118 | | |
Share capital, December 31, 2019
|
| | | | 15,184,152 | | | | | | 15,184 | | |
| | |
January 1,
2018 |
| |
December 31,
|
| ||||||||||||
(美元以千為單位,不包括份額)
|
| |
2018
|
| |
2019
|
| ||||||||||||
已分配、已調用並已全額支付 | | | | | | | | | | | | | | | | | | | |
15,184,152 (2018: 12,917,016) ordinary shares of DKK 1 each (2018: ordinary shares of DKK 1 each)
|
| | | $ | 2,113 | | | | | $ | 2,113 | | | | | $ | 2,481 | | |
| | | | $ | 2,113 | | | | | $ | 2,113 | | | | | $ | 2,481 | | |
擁有的普通股數量
|
| |
2018
|
| |
2019
|
| ||||||
Niels Iversen Møller
|
| | | | 4,292,352 | | | | | | 4,292,604 | | |
Andreas Holm Mattsson
|
| | | | 4,163,832 | | | | | | 4,163,832 | | |
Lars Aage Staal Wegner
|
| | | | 181,872 | | | | | | 182,124 | | |
高管管理合計
|
| | | | 8,368,056 | | | | | | 8,638,560 | | |
|
擁有的普通股數量
|
| |
2018
|
| |
2019
|
| ||||||
Roberto Prego
|
| | | | 307,548 | | | | | | 310,248 | | |
Thomas William Wylonis
|
| | | | 471,096 | | | | | | 481,860 | | |
Steven Projan
|
| | | | – | | | | | | 11,736 | | |
董事會總數
|
| | | | 778,644 | | | | | | 803,844 | | |
(USD in thousands)
|
| |
Convertible loans
|
| |||
Carrying amount at January 1, 2018
|
| | | $ | – | | |
Amount received in 2018
|
| | | | 7,998 | | |
計入財務費用的公允價值調整
|
| | | | 684 | | |
Currency adjustment
|
| | | | (113) | | |
Carrying amount at December 31, 2018
|
| | | | 8,569 | | |
Amount received in 2019
|
| | | | 152 | | |
計入財務費用的公允價值調整
|
| | | | 1,183 | | |
Currency adjustment
|
| | | | (209) | | |
Converted to equity during 2019
|
| | | | (9,695) | | |
Carrying amount at December 31, 2019
|
| | | $ | – | | |
| | |
Assumption applied
|
|
DKK/USD exchange rate
|
| |
0.154
|
|
Discount rate
|
| |
Convertible Debt 1 – 39%
Convertible Debt 2 – 25% |
|
符合條件的融資事件發生的概率
|
| |
95%
|
|
Evaxion share price
|
| |
$5.75
|
|
(USD in thousands)
|
| |
Impact on
Convertible Debt 1 |
| |
Impact on
Convertible Debt 2 |
| ||||||
Exchange rate increased by 5%
|
| | | $ | (48) | | | | | $ | (272) | | |
Exchange rate decreased by 5%
|
| | | $ | 48 | | | | | $ | 272 | | |
Discount rate decreased by 3%
|
| | | $ | (24) | | | | | $ | (85) | | |
融資事件概率降低25%
|
| | | $ | (100) | | | | | $ | (40) | | |
Share price increased by 10%
|
| | | $ | (10) | | | | | $ | (39) | | |
Share price decreased by 10%
|
| | | $ | 10 | | | | | $ | 39 | | |
| | |
December 31,
|
| |||||||||
| | |
2018
|
| |
2019
|
| ||||||
公司與其他關聯方的交易: | | | | | | | | | | | | | |
(USD in thousands) | | | | | | | | | | | | | |
關聯方交易(費用): | | | | | | | | | | | | | |
發行給執行管理層和董事會成員的可轉換債務工具的應計利息
|
| | | $ | (4) | | | | | $ | (4) | | |
年末關聯方餘額(資產)
|
| | | $ | – | | | | | $ | – | | |
年末關聯方餘額(負債): | | | | | | | | | | | | | |
向執行管理層和董事會成員發行的可轉換債務工具(名義價值外加7.5%的應計利息)
|
| | | $ | 117 | | | | | $ | – | | |
| | |
December 31, 2019
|
| |||||||||||||||||||||||||||
(USD in thousands)
|
| |
Contractual
cash flows |
| |
Year
|
| |
1 – 2
years |
| |
2 – 5
years |
| |
>5 years
|
| |||||||||||||||
Purchase obligations
|
| | | $ | 710 | | | | | $ | 587 | | | | | $ | 103 | | | | | $ | 20 | | | | | $ | – | | |
Total
|
| | | $ | 710 | | | | | $ | 587 | | | | | $ | 103 | | | | | $ | 20 | | | | | $ | – | | |
| | | | | |
截至9月30日的9個月
|
| | |||||||||||
| | |
Note
|
| |
2019
|
| |
2020
|
| | ||||||||
| | | | | |
(單位為千美元,每股除外)
|
| | | | |||||||||
Operating expenses: | | | | | | | | | | | | | | | | | | ||
研發
|
| | | | | | $ | 5,270 | | | | | $ | 8,048 | | | | ||
一般和行政
|
| | | | | | | 1,870 | | | | | | 3,875 | | | | ||
總運營費用
|
| | | | | | | 7,140 | | | | | | 11,923 | | | | ||
Operating loss
|
| | | | | | | (7,140) | | | | | | (11,923) | | | | ||
Finance income
|
| | | | | | | 84 | | | | | | 123 | | | | ||
Finance expenses
|
| | | | | | | (1,186) | | | | | | (9) | | | | ||
Net loss before tax
|
| | | | | | | (8,242) | | | | | | (11,809) | | | | ||
Income taxes
|
| | | | | | | 566 | | | | | | 1,055 | | | | ||
Net loss for the period
|
| | | | | | $ | (7,676) | | | | | $ | (10,754) | | | | ||
Evaxion Biotech A/S股東應佔淨虧損
|
| | | | | | $ | (7,676) | | | | | $ | (10,754) | | | | ||
可能重新分類為
的其他全面收入
後續期間損益(税後淨額): |
| | | | | | | | | | | | | | | | | ||
對外業務翻譯匯兑差異
|
| | | | | | | — | | | | | | (6) | | | | ||
後續期間不重新分類為損益的其他全面收入(税後淨額):
|
| | | | | | | | | | | | | | | | | ||
貨幣折算成提示貨幣的匯兑差額
|
| | | | | | | (278) | | | | | | 20 | | | | | |
當期其他綜合損益,税後淨額
|
| | | | | | $ | (278) | | | | | $ | 14 | | | | ||
全面虧損
|
| | | | | | $ | (7,954) | | | | | $ | (10,740) | | | | ||
Evaxion Biotech A/S股東應佔全面虧損總額
|
| | | | | | $ | (7,954) | | | | | $ | (10,740) | | | | ||
Loss per share – basic and diluted
|
| | | | | | $ | (0.57) | | | | | $ | (0.71) | | | |
| | |
Note
|
| |
December 31,
2019 |
| |
September 30,
2020 |
| ||||||
| | | | | | | | | | | |
(unaudited)
|
| |||
| | | | | |
(USD in thousands)
|
| |||||||||
ASSETS | | | | | | | | | | | | | | | | |
Non-current assets | | | | | | | | | | | | | | | | |
Intangible assets
|
| |
2
|
| | | $ | — | | | | | $ | 37 | | |
財產、廠房和設備
|
| | | | | | | 101 | | | | | | 166 | | |
Tax receivables
|
| | | | | | | — | | | | | | 612 | | |
Leasehold deposits
|
| | | | | | | 25 | | | | | | 47 | | |
非流動資產合計
|
| | | | | | | 126 | | | | | | 862 | | |
Current assets | | | | | | | | | | | | | | | | |
Receivables
|
| | | | | | | 575 | | | | | | 1,431 | | |
延期發售成本
|
| |
2
|
| | | | — | | | | | | 631 | | |
Tax receivables
|
| | | | | | | 824 | | | | | | 475 | | |
現金和現金等價物
|
| | | | | | | 9,559 | | | | | | 7,876 | | |
Total current assets
|
| | | | | | | 10,958 | | | | | | 10,413 | | |
TOTAL ASSETS
|
| | | | | | $ | 11,084 | | | | | $ | 11,275 | | |
權益和負債 | | | | | | | | | | | | | | | | |
Share capital
|
| |
5
|
| | | $ | 2,481 | | | | | $ | 2,603 | | |
Other reserves
|
| | | | | | | 22,693 | | | | | | 29,067 | | |
Accumulated deficit
|
| | | | | | | (15,812) | | | | | | (23,767) | | |
Total equity
|
| | | | | | | 9,362 | | | | | | 7,903 | | |
流動負債 | | | | | | | | | | | | | | | | |
Lease liabilities
|
| | | | | | | 36 | | | | | | 38 | | |
Trade payables
|
| | | | | | | 646 | | | | | | 1,502 | | |
Other payables
|
| | | | | | | 1,040 | | | | | | 1,832 | | |
流動負債總額
|
| | | | | | | 1,722 | | | | | | 3,372 | | |
Total liabilities
|
| | | | | | | 1,722 | | | | | | 3,372 | | |
權益和負債合計
|
| | | | | | $ | 11,084 | | | | | $ | 11,275 | | |
| | | | | | | | | | | |
Other reserves
|
| | | | | | | | | | | | | |||||||||
| | |
Note
|
| |
Share
capital |
| |
Share
premium |
| |
Foreign
currency translation reserve |
| |
Accumulated
deficit |
| |
Total
equity |
| |||||||||||||||
Equity at December 31, 2018
|
| | | | | | $ | 2,113 | | | | | $ | 4,106 | | | | | $ | (171) | | | | | $ | (6,979) | | | | | $ | (931) | | |
Net loss for the period
|
| | | | | | | | | | | | | | | | | | | | | | | | | (7,676) | | | | | | (7,676) | | |
其他綜合收益
|
| | | | | | | | | | | | | | | | | | | (278) | | | | | | | | | | | | (278) | | |
基於股份的薪酬費用
|
| | | | | | | | | | | | | | | | | | | | | | | | | 1,725 | | | | | | 1,725 | | |
發行股票換取現金
|
| | | | | | | 163 | | | | | | 8,273 | | | | | | | | | | | | | | | | | | 8,436 | | |
Transaction costs
|
| | | | | | | | | | | | | (13) | | | | | | | | | | | | | | | | | | (13) | | |
可轉換債務工具結算
|
| | | | | | | 187 | | | | | | 9,508 | | | | | | | | | | | | | | | | | | 9,695 | | |
Equity at September 30, 2019
|
| | | | | | $ | 2,463 | | | | | $ | 21,874 | | | | | $ | (449) | | | | | $ | (12,930) | | | | | $ | 10,958 | | |
|
| | | | | | | | | | | |
Other reserves
|
| | | | | | | | | | | | | |||||||||
| | |
Note
|
| |
Share
capital |
| |
Share
premium |
| |
Foreign
currency translation reserve |
| |
Accumulated
deficit |
| |
Total
equity |
| |||||||||||||||
Equity at December 31, 2019
|
| | | | | | $ | 2,481 | | | | | $ | 22,862 | | | | | $ | (169) | | | | | $ | (15,812) | | | | | $ | 9,362 | | |
Net loss for the period
|
| | | | | | | | | | | | | | | | | | | | | | | | | (10,754) | | | | | | (10,754) | | |
其他綜合收益
|
| | | | | | | | | | | | | | | | | | | 14 | | | | | | | | | | | | 14 | | |
基於股份的薪酬費用
|
| | | | | | | | | | | | | | | | | | | | | | | | | 2,799 | | | | | | 2,799 | | |
發行股票換取現金
|
| |
5
|
| | | | 122 | | | | | | 6,504 | | | | | | | | | | | | | | | | | | 6,626 | | |
Transaction costs
|
| |
5
|
| | | | | | | | | | (144) | | | | | | | | | | | | | | | | | | (144) | | |
Equity at September 30, 2020
|
| | | | | | $ | 2,603 | | | | | $ | 29,222 | | | | | $ | (155) | | | | | $ | (23,767) | | | | | $ | 7,903 | | |
| | | | | |
截至9月30日的9個月
|
| |||||||||
| | |
Note
|
| |
2019
|
| |
2020
|
| ||||||
| | | | | |
(USD in thousands)
|
| |||||||||
經營活動: | | | | | | | | | | | | | | | | |
Net loss for the period
|
| | | | | | $ | (7,676) | | | | | $ | (10,754) | | |
非現金項目調整
|
| |
5
|
| | | | 2,313 | | | | | | 1,814 | | |
非流動金融資產 - 租賃存款變動
|
| | | | | | | (7) | | | | | | (20) | | |
Interest received
|
| | | | | | | 1 | | | | | | — | | |
Interest paid
|
| | | | | | | (2) | | | | | | (1) | | |
Income taxes received
|
| | | | | | | — | | | | | | 812 | | |
營運資金變動前的經營活動現金流
|
| | | | | | | (5,371) | | | | | | (8,149) | | |
營運資金變動產生的現金流:
|
| | | | | | | | | | | | | | | |
淨營運資金變動
|
| | | | | | | 559 | | | | | | 104 | | |
經營活動中使用的淨現金
|
| | | | | | | (4,812) | | | | | | (8,045) | | |
投資活動: | | | | | | | | | | | | | | | | |
購置房產、廠房和設備
|
| | | | | | | (14) | | | | | | (77) | | |
購買無形資產
|
| |
2
|
| | | | — | | | | | | (35) | | |
投資活動中使用的淨現金
|
| | | | | | | (14) | | | | | | (112) | | |
融資活動: | | | | | | | | | | | | | | | | |
股票發行收益
|
| |
6
|
| | | | 8,436 | | | | | | 6,626 | | |
發行股票的預付收益
|
| |
6
|
| | | | 744 | | | | | | — | | |
與發行股票相關的交易成本
|
| |
6
|
| | | | (13) | | | | | | (128) | | |
發行可轉換債務工具所得收益
|
| | | | | | | 152 | | | | | | — | | |
Leasing installments
|
| | | | | | | (55) | | | | | | (54) | | |
融資活動提供的現金淨額
|
| | | | | | | 9,264 | | | | | | 6,444 | | |
現金及現金等價物淨增(減)
|
| | | | | | | 4,438 | | | | | | (1,713) | | |
年初現金和現金等價物
|
| | | | | | | 7,433 | | | | | | 9,559 | | |
現金和現金等價物的匯率調整
|
| | | | | | | (400) | | | | | | 30 | | |
現金和現金等價物,期末
|
| | | | | | $ | 11,471 | | | | | $ | 7,876 | | |
| | |
September 30, 2020
|
| |||||||||||||||||||||||||||||||||
(USD in thousands)
|
| |
Carrying
amount |
| |
Contractual
cash flows |
| |
|
| |
1 – 5years
|
| |
>5 years
|
| |
Total
|
| ||||||||||||||||||
Lease liabilities
|
| | | $ | 38 | | | | | $ | 38 | | | | | $ | 38 | | | | | $ | — | | | | | $ | — | | | | | $ | 38 | | |
Trade payables
|
| | | | 1,502 | | | | | | 1,502 | | | | | | 1,502 | | | | | | — | | | | | | — | | | | | | 1,502 | | |
Other payables
|
| | | | 1,832 | | | | | | 1,832 | | | | | | 1,832 | | | | | | — | | | | | | — | | | | | | 1,832 | | |
Total
|
| | | $ | 3,372 | | | | | $ | 3,372 | | | | | $ | 3,372 | | | | | $ | — | | | | | $ | — | | | | | $ | 3,372 | | |
| | | | | | | | | | | |
% equity interest
|
| |||||||||
Name
|
| |
Principal activities
|
| |
Country of
incorporation |
| |
December 31,
2019 |
| |
September 30,
2020 |
| |||||||||
Evaxion Biotech A/S
|
| |
Pharmaceutical R&D
|
| | | | 丹麥 | | | | | | 100 | | | | | | 100 | | |
Evaxion Biotech Australia Pty Ltd
|
| |
Pharmaceutical R&D
|
| | | | 澳大利亞 | | | | |
|
—
|
| | | | | 100 | | |
Participants
|
| |
Estimated
Number of warrants |
| |
Fair value(1)
|
| |
Vesting Term
|
| |
Exercise Price
(DKK) |
| |||||||||
Employees
|
| | | | 73,656 | | | | | $ | 70萬 | | | |
3 years
|
| | | | 1 | | |
Employees
|
| | | | 20,628(2) | | | | | $ | 20萬 | | | |
Immediate
|
| | | | 1 | | |
科學顧問委員會
|
| | | | 20,304 | | | | | $ | 20萬 | | | |
Immediate
|
| | | | 1 | | |
Board of Directors
|
| | | | 27,828 | | | | | $ | 20萬 | | | |
Immediate
|
| | | | 1 | | |
| | |
截至9月30日的9個月
|
| | |||||||||||
(USD in thousands)
|
| |
2019
|
| |
2020
|
| | ||||||||
研發費用
|
| | | $ | 749 | | | | | $ | 1,321 | | | | ||
一般和行政費用
|
| | | | 976 | | | | | | 1,462 | | | | ||
Total
|
| | | $ | 1,725 | | | | | $ | 2,783* | | | | | |
| | |
截至9月30日的9個月
|
| |||||||||
(USD in thousands)
|
| |
2019
|
| |
2020
|
| ||||||
Income taxes
|
| | | $ | (566) | | | | | $ | (1,055) | | |
Depreciation
|
| | | | 51 | | | | | | 76 | | |
Interest income
|
| | | | (1) | | | | | | (1) | | |
Interest expense
|
| | | | 2 | | | | | | 1 | | |
基於股份的薪酬費用
|
| | | | 1,725 | | | | | | 2,783 | | |
可轉換債務工具公允價值變動
|
| | | | 1,183 | | | | | | — | | |
Other adjustments: | | | | | | | | | | | | | |
其他調整,主要是匯率調整
|
| | | | (81) | | | | | | 10 | | |
非現金項目調整合計
|
| | | $ | 2,313 | | | | | $ | 1,814 | | |
| | |
Number of
Ordinary Shares |
| |
Share Capital
(DKK in thousands) |
| ||||||
Share capital, December 31, 2018
|
| | | | 12,917,016 | | | | | | 12,917 | | |
2019年7月17日增資(發行股票換現金)
|
| | | | 997,668 | | | | | | 998 | | |
2019年7月17日增資(轉換可轉換債券)
Debt 1) |
| | | | 302,976 | | | | | | 303 | | |
2019年7月17日增資(轉換可轉換債券)
Debt 2) |
| | | | 848,232 | | | | | | 848 | | |
Share capital, September 30, 2019
|
| | | | 15,065,892 | | | | | | 15,066 | | |
Share capital, December 31, 2019(1)
|
| | | | 15,184,152 | | | | | | 15,184 | | |
2020年9月17日增資(發行股票)
cash) |
| | | | 745,380 | | | | | | 745 | | |
Share capital, September 30, 2020
|
| | | | 15,929,532 | | | | | | 15,930 | | |
(美元以千為單位,不包括份額)
|
| |
December 31,
2019 |
| |
September 30,
2020 |
| ||||||
已分配、已調用並已全額支付 | | | | | | | | | | | | | |
15,929,532 (2019: 15,184,152) Ordinary shares of DKK 1 each
|
| | | $ | 2,481 | | | | | $ | 2,603 | | |
| | | | $ | 2,481 | | | | | $ | 2,603 | | |